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Summary 
The immune system is highly organized and multifunctional; it protects the organism 
against invading pathogens (immune response), while at the same time being tolerant 
to ‘self’ (immune tolerance). Central tolerance is achieved during T-cell development by 
negative selection via self-peptide-MHC complexes (pMHC) presented by thymic 
dendritic cells (tDCs) and medullary thymic epithelial cells (mTECs). However, how self-
antigens are processed into peptides that further are shuttled onto major 
histocompatibility complex (MHC) class II in thymic epithelial cells (TECs) is not fully 
understood. One candidate pathway involved in this process is macroautophagy 
(referred to as autophagy hereafter), originally thought to solely be involved cellular 
housekeeping, has previously been implicated to contribute to MHC class II 
endogenous antigen presentation by TECs. 
This research project investigates the role of autophagy in negative selection by TECs. 
A model antigen was targeted specifically to the autophagosome in autoimmune 
regulator (Aire)+ mTECs. Transgenic mice expressing this antigen were generated. 
Experimental data indicated that the efficient direct presentation of this endogenous 
antigen by mTECs observed in vitro was sufficient to induce negative selection in vivo. 
By contrast, interference with autophagosomal processing of this antigen through 
exchange of one amino acid or disruption of an essential autophagy gene abolished 
endogenous antigen presentation by mTECs and impaired negative selection, which 
resulted in the escape of autoreactive CD4 T-cells. Moreover, further investigation 
showed that if the level of antigen expression was limited, autophagy-dependent direct 
presentation by mTECs was essential for T-cell deletion, while with sufficient amounts 
of antigen provided by mTECs, direct presentation by mTECs and indirect presentation 
by tDCs co-operated to induce central CD4 T-cell tolerance.  
These findings strongly suggest that the autophagy pathway contributes to CD4 T-cell 
tolerance induction by facilitating the loading of intracellular antigens onto MHC class II 
in mTECs. 
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Zusammenfassung 
Das Immunsystem ist sehr strukturiert aufgebaut und hat vielseitige Funktionen, es 
schützt den Organismus vor eindringenden Krankheitserregern (Immunreaktion), 
während es gleichzeitig 'Selbsttoleranz' (Immuntoleranz) aufweist. Die zentrale Toleranz  
wird während der Entwicklung von T-Zellen durch negative Selektion über Eigenpeptid-
MHC-Komplexe (pMHC) von dendritischen Zellen im Thymus (tDCs) und medullären 
Thymusepithelzellen (mTECs) erreicht. Wie allerdings Selbstantigene in Peptide 
prozessiert werden, die weiter auf Haupthistokompatibilitätskomplex- (MHC-Komplex)-
Klasse-II Moleküle von Thymusepithelzellen (TECs) gelangen, ist nicht hinreichend 
verstanden. Ein potenziell involvierter Kandidat ist Makroautophagie (im Folgenden als 
Autophagie bezeichnet), von der man ursprünglich annahm, dass es sich lediglich um 
einen zellulären Homöostase-Prozess handelt, wurde zuvor mit der endogenen MHC-
Klasse-II vermittelten Antigenpräsentation in TECs in Verbindung gebracht. 
Dieses Forschungsprojekt untersucht die Rolle der Autophagie bei der negativen 
Selektion von T-Zellen. Die Expression von einem Modell-Antigen wurde gezielt auf 
Autophagosome in autoimmune regulator (Aire)+ medullären Thymus-Epithelzellen 
gerichtet. Transgene Mäuse, die dieses Modell-Antigen tragen, sind wurden generiert. 
Experimentelle Daten zeigten, dass die effiziente Direktdarstellung dieses endogenen 
Antigens, die durch medulläre Thymus-Epithelzellen in vitro beobachtet wurde, 
ausreichend war, um die negative Selektion in vivo zu induzieren. Im Gegensatz dazu, 
hat die Interferenz mit der autophagosomalen Verarbeitung dieses Antigens, durch den 
Austausch einer Aminosäure oder Störung eines wesentlichen Autophagiegens, die 
durch medulläre Thymus-Epithelzellen herbeigeführte endogene Antigen-Präsentation 
beseitigt und eine negative Selektion zur Folge gehabt, die zur Freisetzung von 
autoreaktiven CD4 T-Zellen geführt hat. Darüber hinaus, zeigten weitere 
Untersuchungen, dass wenn die Antigen-Merkmale begrenzt waren, eine 
Autophagieabhängige Direktpräsentation von medullären Thymus-Epithelzellen für die 
Zerstörung von T-Zell von wesentlicher Bedeutung war, während bei  ausreichenden 
Mengen von Antigenen, die durch medulläre Thymus-Epithelzellen zur Verfügung 
gestellt wurden, bei der direkten Präsentation von medullären Thymus-Epithelzellen und 
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der indirekten Präsentation von tDCs Kooperation  betrieben wurde, um eine zentrale 
CD4 T-Zell-Toleranz herbeizuführen.  
Diese Ergebnisse weisen deutlich darauf hin, dass der Weg der Autophagie zur CD4 T-
Zell-Toleranz-Induktion beiträgt, indem die Belastung von intrazellulären Antigenen bei 
MHC-Klasse-II in medullären Thymus-Epithelzellen ermöglicht wird. 
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1．Introduction 
1.1. Overview 
The immune system contains a variety of exquisitely adapted structures and biological 
processes. Its major function is to recognize and eliminate harmful invaders and foreign 
antigens, as well as maintain tolerance to the host’s own proteins, cells, and healthy 
tissues. To eliminate invaders such as microorganisms, parasites, and viruses, two 
major components of the immune system have evolved: innate and adaptive immunity. 
Innate immunity functions at the initial stage of infection. The skin and mucosa are 
physical barriers that act as the first line of defense to prevent pathogenic 
microorganisms from entering the host. Furthermore, antimicrobial peptides and 
enzymes secreted by mucosa also deter the establishment of infection. Once these 
barriers are breached, innate immune cells such as macrophages and neutrophils 
provide an immediate, but non-specific response against those invaders as the 
secondary line of defense, mediated by accessory molecules that activate signaling 
pathways. Together, these innate protective mechanisms are generally sufficient to 
prevent infection by many microorganisms. However, initiation of the innate immune 
response is restricted as it relies on cellular pattern recognition receptors (PRRs) to 
recognize microbe-specific molecules that are commonly expressed by 
microorganisms1. As microorganisms continually evolve strategies to avoid detection by 
the host’s innate immunity, so the host immune response has co-evolved. The adaptive 
immune system developed as an improved defense strategy to eliminate pathogens that 
escape the innate immune response2.  
The adaptive immune system is believed to have evolved first in jawed vertebrates and 
is activated by the innate immune response. It provides the vertebrate immune system 
with the ability to recognize and target pathogens in a more specific manner. 
Furthermore, this improved response is maintained as immunological memory, which 
results in a faster and stronger immune response when the pathogens are re-
encountered.   
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The adaptive immune system is highly adaptive due to the diversity and specificity of 
antigen receptors expressed by lymphocytes. The specificity of these receptors is 
determined by a genetic mechanism known as variable (diversity) joining (V(D)J) 
recombination, which occurs during lymphocyte development in the bone marrow and 
the thymus. It leads to a rearrangement of the gene segments coding for the antigen 
receptor, which results in a unique antigen receptor expressed on an individual 
lymphocyte. Consequently, a highly diverse lymphocyte receptor repertoire with the 
ability to recognize a myriad of antigens or pathogens is generated. 
1.2 T-cell development   
T-cells initially arise from hematopoietic progenitors, and then migrate to the thymus for 
further differentiation. The thymus as the primary T-lymphoid organ provides essential 
niches and constant signals for supporting to development of thymocytes into mature T-
cells. As thymocytes go through the thymus, they continually receive signals via 
interactions with cortical thymic epithelial cells (cTECs), medullary thymic epithelial cells 
(mTECs), and thymic dendritic cells (tDCs). After a series of selection processes, a 
highly diverse repertoire is generated with thymocytes expressing functional, self-major 
histocompatibility complex (MHC)-restricted T-cell receptors (TCRs). Eventually, these 
mature T-cells migrate to peripheral lymphoid tissues. 
1.2.1 Early T-cell differentiation in the thymus 
The colonization of the thymus with hematopoietic progenitors of myeloid, lymphoid, or 
mixed myeloid/lymphoid potential3, 4 occurs as early as embryonic day 11.5 (E11.5) in 
mice and in the eighth week of gestation in humans5, 6. During the initial phase, 
hematopoietic progenitor cells enter the thymus via the cortico-medullary junction7. 
Although the mechanism that mediates homing to the thymus is not fully understood, 
several chemokine receptors, such as C-X-C chemokine receptor type 4 (CXCR4)8, C-C 
chemokine receptor type (CCR)79, CCR910, and P-selectin glycoprotein ligand-1 
(PSGL1)11 have been implicated to contribute to the migration of immature thymocytes. 
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Based on the temporally coordinated expression profiles of CD44, CD25, and CD127 on 
the surface of thymocytes, early T-cell differentiation can be further subdivided into four 
sequential phenotypic stages (DN1 to DN4). The earliest T-cell progenitors have the 
most immature phenotype, and are characterized as double negative (DN)1 thymocytes 
without expression of CD4 or CD8 surface markers12, 13. At the initial stage, DN1 
thymocytes are CD44+CD127+CD25-. They leave from the cortico-medullary junction of 
the thymus and move towards and into the inner cortex as they commit to the DN2 
stage with the upregulation of CD25. This progress relies on signals mediated by 
thymocyte progenitor-derived NOTCH1, which is activated upon interaction with its 
ligand, delta-like ligand 4 (DLL4) expressed by TECs14, 15, and is supported by signals 
from interactions between cTEC-derived interleukin-7 (IL-7) and IL-7R in T lineage 
progenitors16, 17.  
As DN1 cells commit to the DN2 stage, they proliferate extensively, with increasing in 
number about 100-fold18, 19. DN2 thymocytes undergo further maturation as they 
migrate to the subcapsular region of the thymic cortex and downregulate the expression 
of CD44 and CD127. This indicates entry into the DN3 differentiation stage. At the DN3 
stage, proliferation is halted and marks the first developmental checkpoint for 
committing thymocytes, at which proper TCR gene rearrangement is verified, a process 
known as β-selection20. 
Somatic rearrangement of the TCR genes occurs as DN thymocytes make their way to 
the subcapsular region of the thymus and initiates at the TCRβ locus. The TCRβ locus 
is composed of numerous variable (Vβ), diversity (Dβ), and joining (Jβ) gene segments, 
and a constant (Cβ) gene. Rearrangement occurs at the V, D, and J gene coding region. 
After DJ recombination, randomly selected DJ segments are then rearranged with a V 
segment to generate the VDJ complex that subsequently combines with the constant 
region gene. The translated product of this transcript pairs with pre-TCRα (pTα) chain 
and CD3 to form the pre-TCR complex on the cell surface21. A survival signal will be 
given to the cells for further proliferation and differentiation through using intracellular 
intermediates triggered by the pre-TCR complex, possibly via oligomerization, in the 
absence of ligand for the pre-TCR complex22. Additionally, signaling via at least two 
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other molecules contributes to β selection: CXCR4, a receptor for stromal-derived-
factor-1 (SDF-1)23, 24, and NOTCH125. Concomitantly, pre-TCR signals lead to the 
cessation of TCRβ chain rearrangement and result in allelic exclusion, which ensures 
each individual T-cell only expresses one TCRβ chain26. The existence of β selection, a 
key step in the development of the T-cell lineage, suggests that only those thymocytes 
that successfully rearrange their TCRβ gene and harbor a functional pre-TCR complex 
on their surface are able to survive and undergo further differentiation into the DN4 
stage27.  
As the thymocytes commit to the DN4 stage, CD25 expression is downregulated. DN4 
thymocytes then proliferate extensively to yield abundant progeny cells with co-
expression of both CD4 and CD8 receptors and differentiate to double positive (DP) 
thymocytes. At the DP stage, thymocyte proliferation is again halted, which allows the 
initiation of somatic rearrangement at the TCRα locus. Unlike the TCRβ locus, the 
TCRα locus consists of numerous Vα and Jα gene segments but lacks a D segment. 
The rearranged TCRα chain pairs with TCRβ to form the TCRαβ complex as an intact 
TCR on the cell surface. During the whole expansion phase, the recombination 
activation genes (RAG) are turned off to prevent any premature rearrangement of the 
TCRα locus. During the formation of TCRαβ complexes, expression of receptors in 
response to cytokine signals is ceased and the thymocytes become unresponsive. 
Specifically for interleukin-7 receptor (IL-7R) that is dramatically downregulated to 
weaken the interaction with thymic stromal cells. In addition, high expression of 
suppressor of cytokine signaling 1 (SOCS1), an intracellular inhibitor of cytokine 
signaling, also occurs28. As the αβTCR is generated from random and flexible 
juxtaposition of TCR loci, positive and negative selections are conducted to test whether 
those TCRs are MHC-restricted and not autoreactive.   
1.2.2 Selection processes at the late T-cell differentiation stage  
Selection processes in the thymus ensure that fully differentiated thymocytes fulfill two 
essential prerequisites: that they recognize and respond to foreign peptide-MHC 
complexes, and are tolerant to the self-peptide-MHC complexes (pMHC). Three key 
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events mark the developmental progression of these cells29: (i) positive selection; (ii) 
CD4-CD8 lineage differentiation; (iii) negative selection. 
1.2.2.1 Positive selection 
Positive selection is a process for rescuing DP thymocytes from apoptosis and creating 
a pool of thymocytes expressing self-restricted TCRs. As a requirement for positive 
selection, DP thymocytes possess a newly generated and unselected TCR repertoire 
expressing low levels of TCRαβ complex30. The DP thymocytes migrate further towards 
the deep cortex of the thymus and interact with pMHC expressed by thymic stromal 
cells that are mainly cTECs. Experiments using two-photon laser scanning microscopy 
to track influenza antigen F5-TCR-specific DP cells within the well-characterized 
reaggregate thymic organ culture (RTOC) system revealed a large fraction of F5 DP 
thymocytes in contact with MHC-bearing stromal cells, which are known to provide the 
signals required for positive selection. Two distinct patterns of thymocyte-stromal cell 
contact were identified: 50% of the F5 DP thymocytes maintained a very stable 
interaction with stromal cells during the entire observation period, while the remainder 
displayed a high dynamic contact. This raises the possibility that two modes of TCR 
signaling may occur during positive selection31.  
In contrast to β selection, positive selection is strictly dependent on TCR-pMHC 
interaction between T-cells and cTECs. The frequency of generation of a MHC-
restricted TCR is very low; hence, to avoid the fate of apoptosis resulting from failure to 
be positively selected, DP thymocytes have to rearrange their TCRα locus continuously 
until a productive and appropriate TCRαβ complex is finally generated. However, 
evidence suggests that the average life span of DP cells is only 3–4 days, indicating 
that DP cells need to receive survival signals to be able to proceed with development. 
Several factors, including RAR-related orphan receptor gamma (RORγ) and T-cell-
specific transcription factor 1 (TCF1), are thought to contribute to upregulation of the 
anti-apoptotic molecule, B-cell lymphoma 2 (Bcl2) on DP thymocytes and regulate cell 
survival during positive selection32-34. Despite receiving survival signals, most cortical 
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DP thymocytes still fail to be positively selected and commit to apoptosis at this stage. 
Consequently, only 3–5% of developing thymocytes survive beyond this checkpoint35.   
DP thymocytes must tune their TCR sensitivity to enable better response to low-affinity 
ligands. CD5, a negative regulator of TCR signaling, is involved in tuning the sensitivity 
of DP cells to low affinity for positively selected pMHC ligands36.  Recent studies have 
highlighted the potential roles of the calcineurin/nuclear factor of activated T-cells 
(NFAT) pathway37 and of microRNA (miR) 181a38 in DP thymocyte selection. Crabtree’s 
group showed that the extracellular-signal-regulated kinases (ERKs, including ERK1 
and ERK2) signaling pathway activated by calcineurin is necessary for increasing the 
sensitivity of DP thymocytes to low-affinity ligands to promote positive selection. In 
calcineurin-deficient mice, they demonstrated that pre-selected DP thymocytes depend 
on calcineurin to reach a transient and hypersensitive stage for ERK, which is essential 
to allow responses to low affinity, but positive-selecting ligands37. In addition, miR181a, 
which is highly expressed in the immature thymocyte population and decreases rapidly 
from DN4 to the single positive (SP) stage, was found to increase thymocyte sensitivity 
for TCR engagement by directly downregulating the expression of several 
phosphatases (SH2-containing tyrosine-specific protein phosphatase (SHP2), protein 
tyrosine phosphatase non-receptor type 22 (PTPN22), and dual specificity protein 
phosphatase 5/6 (DUSP5/6)) that inhibit TCR signals38.  
1.2.2.2 CD4-CD8 lineage differentiation 
Following successful TCR recognition of pMHC ligands at low affinity, DP thymocytes 
receive signals for survival and further differentiate to either CD4 or CD8 SP thymocytes, 
which is determined by their restriction to MHC class II or I, respectively. The choice of 
CD4 or CD8 lineage is the key to T-cell functional differentiation. However, the decision-
making process is still not fully understood. Several theory models have been proposed 
to explain how the CD4 vs. CD8 lineage differential decision is made. In these models, 
positive selection and CD4/CD8-lineage commitment occur simultaneously and both 
events are induced by the same TCR signals. TCR signaling during positive selection 
can selectively terminate either CD4 or CD8 gene expression, and the major difference 
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between the proposed models is whether termination of co-receptor transcriptional 
expression is random or instructed. The stochastic selection model suggests that CD4 
or CD8 termination during positive selection occurs randomly. A second TCR-
dependent rescue signal is required for thymocyte survival only if the cells harbor 
matched TCR and co-receptor; otherwise, the cells die39, 40. The instructive model infers 
that MHC class I- and MHC class II-restricted TCR signals are distinct from each other 
and the CD4/CD8-lineage commitment is determined by the strength (strength-of-signal 
instructional model)41 and/or the duration (duration-of-signal instructional model)42 of the 
signals transduced by co-engagement of TCR and co-receptor during positive selection. 
While these three models are experimentally contradicted, the concept that TCR signal 
duration is a major CD4/CD8-lineage determinant remains to be accepted. 
Based on the most recent experimental data, CD4/CD8 lineage choice seems to be 
best explained by the kinetic signaling model43. In this model, positive selection and 
lineage choice are sequential, but not simultaneous. According to observations both in 
vitro and in vivo, it is proposed that TCR-mediated positive selection signals first 
terminate CD8 gene transcription, which converts TCR-signaled DP thymocytes into a 
CD4+CD8low intermediate phase that is still lineage-uncommitted but has the potential to 
differentiate into either CD4 or CD8 SP thymocytes43-45. Then the CD4/CD8 lineage 
commitment is based on whether signaling from TCR persists or ceases after CD8 
downregulation. It means that persistence of TCR signaling in CD4+CD8low thymocytes 
induces the deviation into the CD4 SP lineage. Conversely, cessation of TCR signaling 
in CD4+CD8low thymocytes results in differentiation into the CD8 lineage. The initiation of 
CD4/CD8 lineage commitment in this model is determined by cytokines that use 
receptors belonging to the common cytokine receptor γ-chain (γc) family, such as IL-7, 
as well as several other transcription factors. IL-7 has been shown to promote co-
receptor reversal. Blockage of IL-7R signaling enhances CD4 gene silencing and 
induces the re-initiation of CD8 gene transcription46. Other relevant transcription factors 
in lineage commitment are T-helper-inducing POZ/Krüppel-like factor (ThPOK)47, 48 and 
runt-related transcription factor (RUNX3)49, together with thymocyte selection-
associated high mobility group box protein (TOX)50 and GATA-binding protein 3 
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(GATA3)51. ThPOK, TOX, and GATA3 are responsible for CD4 lineage differentiation52-
54, while only RUNX3 is known to be important in mediating CD8 lineage differentiation49. 
TOX is important for generation of CD4+CD8low intermediate thymocytes after CD8 
termination52. GATA3 promotes ThPOK expression by binding to a region of the ThPOK 
locus required for its expression. ThPOK enhancement of CD4 lineage commitment is 
GATA3-dependent, while inhibition of differentiation into CD8 lineage is independent of 
GATA3 and further prevents RUNX3 from silencing the CD4 locus55. By contrast, IL-7R 
signaling upregulates the expression of RUNX3, which can bind to the CD4 silencer 
element, silencing CD4 expression and inhibiting the expression of ThPOK56.  
 1.2.2.3 An overview of central tolerance mechanisms 
Up to the point in their development described so far, positively selected SP thymocytes 
possess a variety of TCRs comprising a T-cell repertoire of millions of T-cells with the 
potential to recognize all pathogenic entities. However, among these thymocytes, there 
is still a group of T-cell clones bearing TCRs that can recognize self-antigens. If these 
self-reactive thymocytes proceed through the terminal maturation stage and migrate to 
the periphery, they may recognize and respond to self-antigens and consequently lead 
to autoimmunity. However, autoimmune symptoms are not generally observed in the 
normal body. Burnet, in his ‘clonal selection hypothesis’ published in 1959, proposed 
that the clones that are potentially self-reactive will be removed from the T-cell 
repertoire to prevent autoimmunity57. There is strong experimental evidence for the 
‘clonal deletion model’ of immune tolerance demonstrating that autoreactive T-cells are 
indeed purged from the repertoire in the thymus. For example, in mice expressing a 
superantigen (SAg) derived from the mouse mammary tumor virus, SAg-specific Vβ17a 
TCR-expressing T-cells were efficiently eliminated, while Vβ17a T-cells escaped from 
clonal deletion in mice lacking the Sag expression58. Furthermore, several TCR 
transgenic mouse strains that express a self-antigen recognized by a specific TCR have 
been widely used as models to investigate negative selection. Most of these systems 
are designed to express the antigens from transgenes, but in some cases, such as H-Y, 
the antigen is naturally expressed (see review29).   
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About 20 years later, Le Dourain and colleagues tested whether there were other 
mechanisms regulating central tolerance. They found that transplantation of embryonic 
limb buds from quail into age-matched chicken embryos led to rejection of grafted 
tissues soon after birth. Interestingly, if limb buds with embryonic thymi were 
simultaneously transplanted into recipients, the grafted limb buds were accepted59, 60. 
This unexpected finding revealed the importance of the thymic epithelium (TE) for 
induction of central tolerance because the embryonic thymi were grafted before they 
had been colonized by hematopoietic cells. More importantly, it demonstrated that the 
recessive tolerance induction mechanism (clonal deletion) could not explain why the 
transplanted limb buds were accepted.  
Although in certain transgenic models the clonal deletion of antigen-specific T-cells is 
efficient, the deletion of polyclonal T-cells is incomplete because autoreactive T-cells 
with downregulated TCR can be found in the periphery61. This observation raises the 
question of whether there could be an additional mechanism for tolerance induction. 
Modigliani and colleagues found that reconstitution of athymic mice with grafted 10-day-
old embryonic thymi led to normal numbers of T-cells generated. When transferring of 
these CD4+ T-cells from such TE chimeras into athymic recipients, it exhibited life-long 
tolerance to syngeneic skin grafts. Importantly, hematopoietic cell colonization still does 
not switch on in 10-day-old embryonic thymi. These data imply that a special type of TE-
selected CD4 T-cell may be generated in the thymus and acquires the capacity to inhibit 
graft-reactive T cells62. However, the existence of such T-cell was still a puzzle. In the 
same year, a subset of T-cells with regulatory function (regulatory T-cell; Treg) had 
been finally identified by Sakaguchi’s group. The cells were of the CD4 T-cell lineage 
constitutively expressing the IL-2R α chain (CD25)63 and had the capacity to suppress 
those effector T cells that are activated upon exposure to their cognate antigen. The 
transcription factor forkhead box protein P3 (FOXP3) has been proposed to be the key 
regulator64, 65 involved in Treg development. This comes from the finding that severe 
autoimmune manifestations result from impaired Treg induction in the ‘scurfy’ mouse 
and in humans with the genetically equivalent IPEX syndrome, because of a frame-shift 
mutation in the FOXP3 gene that affects the forkhead/winged-helix domain of the 
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FOXP3/scurfin protein66-68. Hence, a new mechanism of tolerance induction, termed 
‘dominant tolerance’, had been discovered and it is now generally accepted that 
recessive and dominant mechanisms co-operate to establish immune tolerance. 
Negative selection and induction of Tregs will be discussed separately in the following 
sections.  
1.2.2.3.1 Recessive tolerance – negative selection 
As immature DP thymocytes develop into mature SP thymocytes, cortical DP cells show 
an increased expression of the chemokine receptor CCR7 and transit from the cortex to 
the medulla31. CCR7 ligands, C-C motif chemokine (CCL)19 and CCL21, are 
predominantly produced by mTECs in the postnatal thymus69, 70. Therefore, thymocytes 
that receive TCR-mediated signals are attracted to the medulla through CCR7-mediated 
chemotaxis. Indeed, positively selected mature thymocytes are found in the cortex and 
central tolerance breaks down if the thymocyte homing pathway is blocked in CCR7- 
and CCR7 ligand-deficient mice69. Subsequent studies have shown that the thymic 
medulla has an indispensable role in negative selection. Intuitively, the medulla is the 
likely site for conducting negative selection, as it provides the most complex ligandome. 
To achieve successful negative selection, the thymus needs to present self-antigens 
that are expressed ubiquitously or are tissue-restricted. The medulla is heavily 
colonized by thymus-homing hematopoietic antigen presenting cells (APCs) capable of 
bringing ubiquitous antigens from the peripheral blood71. In addition, the main stromal 
cell subset residing in the medulla, mTECs, are capable of expressing a wide range of 
tissue restricted self-antigens (TRAs), which is termed as ‘promiscuous gene 
expression’. It has been estimated that around 2000–3000 TRAs are expressed by 
human and murine mTECs72-74.  
Kyewski’s group demonstrated that a individual TRA is expressed by only 1–3% of total 
mTECs73, 75. Most TRA-expressing mTECs have a mature phenotype, with high 
expression of MHC class II and the co-stimulatory molecule CD80 (mTEChi)73. The 
mTEC subset in general is rapidly replaced, and the terminally differentiated mTEChi 
has an even higher turnover rate76, 77. Therefore, TRA expression by mTECs is a 
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dynamic process. The topology of mTECs constantly changes and provides a source of 
extracellular antigens for neighboring tDCs to mediate cross-presentation. Meanwhile, it 
has been found that the medulla contains a substantial fraction of semi-mature, HSAhi 
CD4 SP T-cells that are still sensitive to tolerance induction78. SP thymocytes are 
assumed to spend 4–5 days in the medulla before export from the thymus79. During this 
period, the SP thymocytes go through a maturation process that can be differentiated 
according to expression of CD62 ligand (CD62L) and CD69; from CD62LloCD69hi semi-
mature SP cells convert to CD62LhiCD69lo mature SP thymocytes80, 81. 
The importance of thymic TRA expression has been emphasized by the study of the 
rare human immune disorder autoimmune polyendocrine syndrome type 1 (APS-1), 
which is characterized by a spectrum of autoimmune diseases caused by mutations in 
the autoimmune regulator (AIRE) gene82, 83. Expression of AIRE is highest in mature 
mTECs, while tDCs express a much lower level73. Studies have shown that mTECs of 
AIRE-deficient mice have a significant reduction in TRA expression. As a consequence, 
these animals have multi-organ autoimmunity accompanied by inflammatory infiltrates 
and autoantibody production84. Analysis of AIRE-deficient mTECs reveals that 
expression of some (approximately 500) but not all TRAs, including the archetypal 
autoantigen insulin and salivary protein 1, is regulated by AIRE73, 84. Although the 
molecular mechanism of how AIRE regulates the transcription of TRAs is not well 
understood, its functional domains and several interacting partners have been identified. 
One important domain, caspase-recruitment domain (CARD), implicates the homo-
oligomerization of AIRE85. Interaction between the CARD of AIRE with protein inhibitor 
of activated STAT1 (PIAS1) is important for the formation of AIRE-associated nuclear 
structures86. A second important domain in AIRE is a SAND (SP100, AIRE1, 
NucP41/P75, and DEAF1) domain, the presence of which suggests that AIRE 
participates in DNA binding. A third one, a plant homeodomain (PHD) zinc finger 
domain, interacts with the DNA-dependent protein kinase (DNA-PK) complex, and the 
residues Thr68 and Ser156 of AIRE protein are DNA-PK phosphorylation sites. By 
introducing mutations into these sites, transcription activated by AIRE is markedly 
decreased87. The presence of these functional domains in the AIRE gene and the 
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known interactions suggest that AIRE mediates transcriptional regulation of target 
genes. Furthermore, it has been reported that the first PHD zinc finger of AIRE 
preferentially binds to the non-methylated histone H3 lysine 4 (H3K4me0)88, indicating 
that AIRE could function as a transcriptional activator to initiate expression of target 
genes. Additionally, the interaction of AIRE with the transcriptional co-activator CREB-
binding protein (CBP)89 and the positive transcription elongation factor b (P-TEFb)90 
also imply enhancement of gene expression mediated by AIRE. Nevertheless, the full 
picture of AIRE-mediated gene activation is still incomplete. A recent study by 
Abramson et al. integrates these scattered pieces into a framework to rationalize how 
AIRE affects those particular genes91. By combining mass spectrometry-based 
screening with co-immunoprecipitation and RNA interference, four groups of AIRE-
interacting partners were identified and classified, from which a model was proposed 
integrating the complexes formed by these partners with AIRE, as well as the distinct 
processes in which they participate (including alteration of chromatin structure, incitation 
of DNA-damage response, gene transcription initiation or repression, regulation of RNA 
processing, and enhancement of nuclear transport). 
According to the ‘clonal selection theory’, an innocuous T-cell repertoire requires the 
elimination of those thymocytes that express TCRs with a high affinity (that is, above a 
certain quantifiable threshold) for self-antigens. Since the same upstream TCR signaling 
pathways are used in both positive and negative selection, how a TCR makes the 
distinction remains elusive. Several signaling molecules regulating negative selection 
have been identified. c-CbI is thought to negatively regulate TCR signaling in 
thymocytes. A mutation in the c-CbI RING finger domain abolishes its function as an E3 
ubiquitin ligase. Knock-in mice bearing this RING finger domain mutation (c-CBI C379A) 
exhibited a nearly complete thymic deletion with much less proportion of mature CD4 
and CD8 SP thymocytes, and this mutation increased sensitivity to TCR-mediated 
apoptosis. Meanwhile, TCR signaling could be promoted, as reflected by the enhanced 
activation of ZAP70, JNK, and p38 MARK92. Another factor with a potential crucial role 
in negative selection is misshapen/Nck interacting kinase (NIK)-related kinase (MINK)93, 
which is expressed at high levels in DP thymocytes94. Knocking down the expression of 
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MINK in bone marrow cells by siRNA prior to reconstitution confers a specific defect on 
negative selection in several models, including HY-TCR and ovalbumin (OVA)-specific 
TCR (OT-II) transgenic mice, but has no effect on positive selection. Furthermore, 
consistent with the role of MINK in negative selection, phosphorylation of JNK, but not 
ERK, is affected by downregulation of MINK expression and it also causes impaired 
BIM expression93. In short, these data suggest that MINK can specifically regulate the 
JNK pathway, and thereby decide the fate of thymocytes. 
Clonal deletion generally eliminates cells by apoptosis, and the key initiator proteins in 
this process are the pro-apoptotic BCL2 family members BIM, BAX, and BAK95, 96. 
Experimental data show that deficiency of BIM or combined deficiency of BAX and BAK 
cripple negative selection97. In fact, in a number of different model systems, BIM is the 
dominant protein for inducing apoptosis in thymocytes96. However, Baldwin’s group 
observed that BIM-mediated apoptosis was not required for negative selection in mice 
transgenic for a TCR specific for a ubiquitously expressed self-antigen98, 99. Another 
crucial effector during clonal deletion is the orphan nuclear receptor Nur77 (also known 
as nerve Growth factor IB (NGFIB)). Evidence for its role in negative selection comes 
from transgenic mice overexpressing a dominant negative version of Nur77, which had 
a defective thymocyte deletion100. Furthermore, Winoto’s group reported that Nur77 
could translocate from the nucleus to the mitochondria. By directly interacting with BCL2, 
it converted BCL2 from an anti-apoptotic protein into a pro-apoptotic protein101. The 
same conformational change in BCL2 was noted in DP thymocytes undergoing negative 
selection in two TCR transgenic mouse models101.  
1.2.2.3.2 Dominant tolerance – Treg generation 
The random rearrangement of TCR gene segments generates not only a functional T-
cell repertoire, but also a group of potentially dangerous T lymphocytes. Clonal deletion 
and anergy are the mechanisms that mediate elimination of autoreactive T-cells bearing 
high affinity TCRs for pMHC. However, even in healthy individuals negative selection is 
inevitably incomplete, leading to the appearance of T lymphocytes that harbor the 
potential to recognize ‘self’. It is proposed that tolerance is maintained in this 
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circumstance by the contribution of Tregs. Direct evidence for this comes from 
experiments showing that depletion of Tregs from 3-day-old mice caused development 
of autoimmune disease, which could be relieved by the re-introduction of Tregs63.  
Treg differentiation is thought to occur mainly in the thymic medulla. This notion is 
supported by experiments with neonatal bone marrow chimeras, which revealed that the 
first wave of FOXP3+ Treg generation is initiated from thymocytes of the semi-mature, 
HSAhi CD4 SP stage, which reside in the medulla102. It indicates that Treg differentiation 
can be spatially and temporally separated from positive selection occurring in the thymic 
cortex. Neonatal thymectomy in mice leads to severe autoimmunity63 and a Treg subset, 
so-called natural Treg (nTreg), is identified in the thymus, which indicates that Treg 
differentiation is an important branch deviating from mainstream T-cell development 
during intrathymic maturation. 
This raises the question of how these autoreactive thymocytes avoid being deleted and 
deviate into the Treg lineage when self-antigens are encountered. TCR stimulation is 
regarded as the essential driving force for thymocyte development. However, the 
intrinsic properties of TCR specificities are clearly unlikely to be involved in the fate 
decisions in thymocytes. Several investigations have shown that some transgenic TCR-
bearing (e.g., with hemagglutinin (HA)-specific TCR) T-cells undergo differentiation into 
the Treg lineage after encountering self-antigen103-105, while others report a massive 
loss of T cells by clonal deletion upon the same intrathymic antigen encounter106, 
107.Taken together, the data imply that some co-stimulatory or cytokine signaling is 
provided by a combination of extrinsic and intrinsic factors that are crucial for Treg 
differentiation in the thymic medulla. CD28-B7 signaling has emerged as important in 
Treg differentiation because of the finding that the proportion and numbers of thymic 
Tregs were severely reduced in mice with genetic ablation of either CD28 or its 
ligands108-110. In addition, CTLA4 signaling shows a reciprocal effect on Treg 
differentiation. Overexpression of full-length CTLA4 resulted in an impaired efficacy of 
SAg-specific thymocyte deletion111. The ‘two-step model’ supports Treg development is 
segregated into a TCR-driven ‘instructive’ phase and a cytokine-driven ‘consolidation’ 
phase112, 113, thus, the importance of another candidate signaling pathway, such as via 
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IL-2 and other γc-dependent cytokines, which co-operates with a TCR stimulus and 
skews development towards Tregs, is also plausible. It is supported by evidence that in 
IL-2/IL-7/IL-15-deficient or STAT5-deficient mice, interference with cytokine signaling via 
γc led to a greater reduction in Tregs114-116. Furthermore, it has been reported that 
transforming growth factor β (TGFβ) is required for thymic Treg generation. With the 
ablation of TGFβRI or TGFβRII117, 118, the first wave of thymic Treg generation is 
diminished. It is feasible that the loss of Tregs could be compensated by an IL-2-
dependent expansion of residual Tregs. And in fact, a complete depletion of thymic 
Tregs is observed in mice with deficiencies in both TGFβ- and IL-2-signaling 
pathways118. 
Collectively, both recessive tolerance and dominant tolerance are essential for 
developing a normal immune system and preventing autoimmunity. That both are 
required is highlighted by the observation of even more severe autoimmune 
manifestations in mice dually deficient in Aire and Foxp3, compared with mice with each 
sole deficiency119. 
1.2.3 Cell-interactions in the thymic microenvironment 
The scope of central tolerance is determined by developing thymocytes recognition of 
self-antigens presented by various APCs in the thymus. A central element in this 
process is the promiscuous expression of TRAs by mTECs. Since a given TRA can only 
be detected in 1–3% of mTECs, the mechanism by which a restricted TRA expression 
pattern in mTECs engages complete tolerance is still debated. Two hypotheses have 
recently been proposed. The first one provided by Le Borgne’s groups proposed that 
after reaching the medulla, thymocytes were highly motile, randomly ‘walking’ at a rate 
of >10 µm/min, and this movement was restricted in a limited globular volume. However, 
they observed that when the negatively selecting self-antigen (OVA) was present, OT-I 
cells demonstrated a more confined motion pattern with a lower velocity and prolonged 
contact with APCs120. Consequently, it is feasible that thymocytes scan the medullary 
region efficiently through serial interactions with APCs to achieve negative selection in 
their 4–5 day residence time. The second one came from the study of Millet and 
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colleagues proposed that intact membrane domains of pMHC at the surface of mTECs 
and/or intracellular antigens expressed by mTECs could spread to neighboring cells, 
including DCs. Evidence for intercellular transfer of membrane components comes from 
experiments in which membrane dye (green fluorescent protein (GFP)) in combination 
with MHC molecules could be detected in GFP-negative epithelial cells when co-
cultured with GFP-expressing cells. Additionally, analysis of chimeric mice confirmed 
that epithelial cells were indeed able to transfer MHC to DCs in vivo in a polarized way. 
Around 5% of tDCs in the recipients acquired MHC molecules121. Furthermore, Koble et 
al. found that the interaction between mTECs and DCs resulted in mTEC-derived 
antigen transferring to DCs, which consequently led to a more efficient antigen 
presentation when compared to endogenous antigen presentation solely mediated by 
DCs themselves. Meanwhile, a subset of DCs bearing a mature phenotype (high 
expression of CD80, CD86, CD103, and MHC II) has been identified, and this mature 
subset was able to acquire TEC-derived membrane receptors as well as cytoplasmic 
proteins122.  
In the thymus, reciprocal interactions between developing thymocytes and TECs are 
bidirectional. It not only commits TECs to educate thymocytes for differentiation by 
presenting antigens to their TCR, but also activates the necessary signaling for TEC 
maturation and function via production of some factors by developing T-cells. This 
phenomenon is termed ‘thymic crosstalk’7, 123, 124. While cTEC development is poorly 
understood, two non-redundant pathways of CD4 SP thymocytes, mediated by the 
ligands LTα/LTβ, RANKL, and CD40L, are known to contribute to mTEC development. 
Independent studies from three separate groups demonstrated that RANK/RANKL and 
CD40/CD40L interactions between mTECs and CD4 thymocytes co-operate to generate 
mature mTECs for postnatal homeostasis, while the earlier stage of mTEC development 
is regulated by RANKL+ lymphoid tissue inducer (LTi) cells before the emerging of 
mature thymocytes125-127. Moreover, data from Irla’s group show that the provision of 
ligands to TCRs requires the direct interaction of autoreactive CD4 thymocytes with 
mTECs that are presenting self-peptide-MHC class II complexes in an antigen-specific 
manner128.  
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1.3 Antigen processing 
1.3.1 The MHC class I and class II pathways 
MHC class I molecule is a heterodimer expressed on the surface of all nucleated cells in 
the body. It comprises a polymorphic heavy chain (consisting of a α1, α2, and α3 
domain) non-covalently linked to a non-polymorphic light chain called β2-microglobulin 
(β2m). The α1 and α2 domains are folded to form the MHC peptide-binding groove, 
which accommodates a peptide of 8–11 amino acids in length. The α3 domain contains 
a transmembrane (TM) domain and interacts with CD8 co-receptor. Both chains are 
synthesized in the endoplasmic reticulum (ER). Prior to peptide loading, the MHC class 
I molecules are inherently unstable and require binding with ER-resident chaperones 
such as calreticulin, the ER oxidoreductase ERp57, and protein disulphide isomerase 
(PDI)129. Furthermore, the binding of calreticulin results in a more stable interaction 
between MHC class I molecules and TAP-associated glycoprotein (tapasin)130, which is 
a transmembrane glycoprotein and plays an important role on peptide loading and 
further peptide transport across the ER membrane. This combination forms a large 
multimeric complex (consisting of transporter associated with antigen presentation 
(TAP), tapasin, MHC class I, calreticulin, and ERp57), called the peptide-loading 
complex (PLC). 
MHC class I molecules present peptides, generated by proteasome-mediated 
degradation of cytosol-derived proteins, at the cell surface. The proteasome, which 
consists of a 20S core barrel with proteolytic activity131 and two 19S caps, is responsible 
for the degradation of intracellular ubiquitinated proteins into small peptides, and the 
catalytic function is performed by three subunits, β1, β2, and β5 (in the constitutive-
proteasome) or β1i, β2i, and β5i (in the immunoproteasome). Immunoproteasomes are 
constitutively expressed in the primary and secondary lymphoid organs. Interferon 
(IFN)-γ, in particular, induces the formation of immunoproteasomes during 
inflammation132, 133. 
Recent findings have suggested that positive selection requires unique MHC-associated 
peptides that are generated by the action of intracellular proteolytic enzymes exclusively 
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expressed by cTECs134. A database search revealed that a previously unrecognized 
catalytic subunit of proteasomes, thymus-specific β5 family member (β5t), is exclusively 
expressed in cTECs; β5i, however, is expressed in a broad range of immune tissues133. 
The β5t-containing proteasome, which associates with β1i and β2i subunits over β1 and 
β2 in cTECs, is termed the thymoproteasome and exhibits proteolytic activity to produce 
cytoplasmic peptides that is distinct from β5- or β5i-containing proteasomes. In β5t-
overexpressing cells, the chymotrypsin-like activity of the 20S component is reduced by 
60–70%; however, protein-degradation activity shows normal. In addition, in β5t-
deficient mice, positive selection of MHC I-restricted transgenic TCR is impaired, along 
with a marked reduction in the number of CD8 SP thymocytes, while CD4 SP T-cell 
development is unaffected. Taken together, the thymoproteasome is proposed to 
increase the repertoire of cytoplasmic self-peptides specific to cTECs compared to 
those epitopes generated by constitutive proteasomes and immunoproteasomes134, 135 
136.  
The peptides that result from proteasomal degradation are released into the cytosol. 
Therefore, they have to be translocated from the cytosol into the lumen of the ER by 
TAP to access MHC class I molecules. As tapasin recruits MHC class I molecules to 
TAP, the coupled peptide is translocated into the ER137. Before binding to MHC class I 
molecules, the peptide may require further trimming to generate the required length of 
8–11 amino acids for MHC class I loading138. Trimming is performed by one ER 
aminopeptidase (ER aminopeptidase associated with antigen processing; ERAAP) in 
mice and two (ER aminopeptidase (ERAP) 1 and ERAP2) in humans139-141. Once a 
peptide with sufficient affinity is loaded onto the MHC class I molecules, the MHC class I 
complexes are released from the chaperones and leave the ER through the secretory 
pathway to be presented at the cell surface. Conversely, peptides that fail to associate 
with MHC class I molecules in the ER are returned to the cytosol for either 
degradation142 or further trimming for a new round of TAP translocation and MHC class I 
loading143 (Graphic 1). 
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Graphic 1. The basic MHC class I antigen presentation pathway. MHC class I molecules are 
synthesized in the endoplasmic reticulum (ER) and stabilized by binding of calreticulin and 
ERp57. Intracellular antigens are degraded by proteasomes which results in peptides released 
into the cytosol and translocated into the lumen of the ER via TAP and tapasin. For binding to 
MHC class I molecules, the peptides require further trimming via ERAPs. The stable MHC class 
I complexes are then transported through the Golgi and presented at the cell surface. 
Unlike the ubiquitously expressed MHC class I molecules, expression of MHC class II 
molecules is restricted to the steady-state APCs, such as DCs, macrophages, B cells 
and, importantly, on cTECs and mTECs. Thus, TECs are the only non-hematopoietic 
cell types that constitutively express MHC class II. However, MHC class II expression 
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can be upregulated on fibroblasts, other mesenchymal stromal cells, endothelial and 
epithelial cells, by IFN-γ or other inflammatory stimuli144, 145.   
Like MHC class I, MHC class II molecules are also heterodimers, and consist of two 
peptide chains, MHC II-α and MHC II-β. Both α- and β-chains of MHC class II are 
transmembrane proteins, which are synthesized in the ER and assembled with the help 
of ER-resident chaperone proteins such as calnexin. Compared with the smaller 
peptide-binding groove on MHC class I molecules, the peptide accommodated in the 
open-ended groove of MHC class II molecules is much longer, generally between 10 
and 24 amino acid residues. To prevent premature peptide loading onto MHC class II 
molecules, the assembled MHC class II αβ heterodimer associates with the invariant 
chain (Ii) in the ER146.  It is believed that the class II-associated Ii peptide (CLIP) region 
of Ii occupies the MHC class II binding groove. Indeed, the levels of endogenous 
antigen presentation are higher in Ii-deficient mice147. However, biochemical analysis 
suggests that it is hard for any MHC class II molecules to gain a stable peptide-loaded 
state in the absence of li during peptide loading148, 149.The resulting Ii-MHC class II 
complexes are then guided via the cytoplasmic tail of Ii and transported through the 
Golgi to the late endosomal/lysosomal compartment150 termed as the MHC class II 
containing compartments (MIICs), which contain endocytosed and degraded proteins. Ii 
is degraded in the MIICs by lysosomal hydrolysis and the CLIP fragment is left in the 
peptide-loading groove to prevent further peptide binding to MHC class II molecules. 
Afterwards, CLIP is released and subsequently replaced by an antigenic peptide with 
the help of the HLA-DM chaperone. This assistance stabilizes the ‘empty’ groove of the 
MHC class II dimer by preventing its aggregation or degradation prior to loading with an 
appropriate epitope, and further facilitates the exchange of CLIP to a specific peptide 
derived from proteolytic degradation of endosomal proteins.  
MHC class II, HLA-DM, and cathepsins have been defined in vitro as the minimal 
requirements for MIIC formation151. Cathepsins are lysosomal proteases involved in Ii-
mediated antigen processing152. Strikingly, tissue-specific expression of distinct 
cathepsins in the thymus has been observed: a unique cathepsin (Cat)-L is exclusively 
expressed in cTECs, while Cat-S is predominantly expressed in mTECs, tDCs153. In 
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Cat-L-deficient mice, an increased number of MHC II/CLIP complexes instead of normal 
MHC II/peptide complexes is found expressing on the surface of cTECs153, leading to a 
70% reduction in total thymic CD4 T-cells154, 155. Moreover, analysis of mice deficient in 
both Cat-L and Ii indicates that impaired CD4 T-cell selection is not solely due to the 
inefficient degradation of Ii156. The evidence suggests that Cat-L in cTECs may be 
directly involved in MHC class II presentation by determining the positively selecting 
peptide repertoire. In addition, the involvement of distinct proteases of different APCs in 
the thymic cortex or medulla for MHC class II presentation suggests that different 
peptide repertoires generate for either positive or negative selection in order to minimize 
extensive thymocyte deletion. 
Thymus-specific serine protease (TSSP), discovered during a screen for cTEC-specific 
genes, is another lysosomal protease with a potentially crucial role in MHC class II 
antigen processing157-159. Although the CD4 polyclonal repertoire shows no significant 
alteration in TSSP-deficient mice160, there is a severe impairment of positive selection in 
OVA- or H-Y-specific CD4 T-cells when TECs lack TSSP161. Consistent with its 
endosomal localization, these data demonstrate that TSSP participates in the 
generation of peptides for positive selection. A link between mutations in PRSS16, the 
gene coding for TSSP, and human autoimmune diabetes susceptibility161 prompted an 
investigation of the development of CD4 T-cells specific to some islet antigens, such as 
phogrin, in non-obese diabetes (NOD) TSSP-deficient mice. The differentiation of 
phogrin-specific CD4 T-cells is highly defective in TSSP-deficient NOD mice. What is 
more, bone marrow chimeras highlight the importance of TSSP in thymic DCs for 
generating a unique peptide repertoire to be negatively selected. Data gained from 
chimeras show that differentiation of islet antigen-specific CD4 T-cells is affected when 
bone marrow-derived APCs lack TSSP expression162. Similarly, TSSP was found to 
regulate the selection of CD4 T-cells specific for some β-cell antigens in NOD mice162. 
Deletion of diabetogenic CD4 T-cells is enhanced in TSSP-deficient mice, further 
supporting a role for TSSP in MHC class II antigen processing. 
After binding of high-affinity peptides to MHC class II molecules, the MHC II/peptide 
(MHCII/p) complexes are transported from the MIIC to the plasma membrane. However, 
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the molecular basis for this process is largely undefined. It is known that transportation 
of the MHCII/p complexes is driven by microtubule-based motors or actin-based myosin 
motors, and that in DCs, the late endosomal/lysosomal compartments are triggered by 
lipopolysaccharide to form tubule-like structures and then generate vesicles containing 
MHCII/p complexes that can fuse with the plasma membrane163, 164 (Graphic 2). 
 
Graphic 2. The basic MHC class II antigen presentation pathway. MHC class II α- and β-
chains are assembled in the endoplasmic reticulum (ER) and associated with the invariant chain 
(Ii). The Ii-MHC class II complexes are then transported through the Golgi to MHC class II 
containing compartments (MIICs) and fuse with late endosomal/lysosomal compartments that 
contain processed proteins during endocytosis. The MHC class II peptide loading groove 
remains be occupied by CLIP fragments which would be exchanged to peptides derived from 
the late endosomal/lysosomal compartments with the help of the HLA-DM chaperon. MHC class 
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II molecules with peptides are then transported to the plasma membrane for antigen 
presentation.  
1.3.2 Alternative MHC class II antigen loading pathways 
Several lines of evidence support the notion that intracellular antigen can also access 
MHC class II presentation pathway. In early studies, an analysis of peptides eluted from 
MHC class II molecules revealed that a substantial amount of natural MHC class II 
ligands (up to 20%) were derived from cytosolic and nuclear proteins165, 166. This 
observation was further verified by analysis of a repertoire of 400 constitutive MHC 
II/peptide complexes in human B cells. While the largest fraction (40%) of peptides 
loaded onto MHC class II was of membrane origin, a relatively large proportion (roughly 
35%) was derived from a diverse pool of intracellular-derived antigens, including 
metabolic enzymes, nuclear and cytoskeletal proteins, viral and tumor antigens, and 
mitochondrion-derived peptides167.  
The first evidence of presentation of these endogenous complexes came from studies 
by Long and colleagues on viral antigen presentation to CD4 T-cells. They found that 
cytosol-synthesized antigens from measles virus and type A influenza virus are 
endogenously presented to MHC class II, and further are recognized by CD4 T-cells for 
activation168. Increasing amounts of data now demonstrate that various intracellular 
antigens, including self-, model-, viral- and tumor-antigens can gain access to the 
endogenous MHC class II antigen presentation pathway167, 169-171, thereby broadening 
the MHC class II ligand repertoire. The classical, endocytic antigen presentation 
pathway clearly does not explain satisfactorily why there is such a large proportion of 
intracellular- and organelle-derived epitopes presented on MHC class II molecules.  
Earlier work suggested the existence of an endogenous processing pathway for MHC 
class II-restricted presentation172, which revealed that both exogenous and endogenous 
antigens could be shuttled into MHC class II loading. Recently, studies have implicated 
multiple pathways to mediate MHC class II presentation of endogenous antigens in both 
professional and nonprofessional APCs. These pathways include the TAP-dependent 
pathway, intercellular antigen transfer, and the autophagy pathway.  
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Experimental evidence for the contribution of the TAP-dependent pathway to cytosolic 
MHC class II-restricted presentation comes from the study of Tewari and colleagues173. 
They revealed that proteasome-dependent cytosolic processing is required for the 
generation of two MHC class II-restricted epitopes from the HA and the neuraminidase 
(NA) glycoproteins of influenza virus. TAP and recycled MHC class II molecules were 
shown to be essential for epitopes to be presented onto the surface of APCs.  
The supporting evidence for intercellular antigen transfer came from Taylor’s group174; 
they showed that two nuclear antigens from EBV could gain access to the MHC class II 
pathway and be presented in EBV-transformed B cells. Endogenous MHC class II 
presentation of these two antigens could not be inhibited by treatment with 3-
methyladenine (3-MA), which blocks autophagy. However, this presentation process 
could be observed in antigen-negative cells by co-cultivation with antigen-positive cells 
or exposure to their culture medium.  
Autophagy, an intracellular bulk degradation process, is also thought to be responsible 
for endogenous MHC class II antigen presentation169, 170, 175-177. This will be discussed in 
detail in the following section. 
1.3.3 Autophagy, a candidate pathway for endogenous antigen loading   
Autophagy is a term derived from the Greek words for ‘self-eating’. It is a highly 
conserved cellular homeostatic process in all eukaryotic organisms, and refers to a 
cellular degradation pathway in which portions of cytoplasmic constituents are 
segregated and transported to the lysosome for degradation. These degraded products 
will then be released and recycled in cellular bio-synthesis. Three major forms of 
autophagic cargo delivery pathways to lysosomes have been identified (shown in 
Graphic 3): microautophagy, chaperone-mediated autophagy, and macroautophagy178, 
179.  
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Microautophagy is a constitutively active, nonselective catabolic process in mammals. 
Components of cytosol portions first form tubules or vesicles, and then they are 
imported to the lysosomes via lysosomal membrane invaginations. Proteins are 
continuously degraded in the lysosomal lumen180. Studies on microautophagy have 
been limited to yeast and cell-free systems, and there is still little understanding of the 
molecular mechanism of microautophagy in mammals181, 182.  
Chaperone-mediated autophagy (CMA) is a selective autophagic pathway that 
delivers cytoplasmic contents to the late endosome/lysosome for degradation183. Unlike 
microautophagy, delivery of cargo via CMA does not involve the formation of vesicle 
compartments at the surface of the lysosomes. Instead, CMA substrates are directly 
translocated from the cytosol into the lysosomal lumen, and this process requires 
unfolding of the substrate proteins184, 185. A prerequisite of a CMA substrate is the 
presence of an amino acid sequence motif biochemically related to KFERQ186. KFERQ 
or KFERQ-like motifs are present in approximately 30% of cytosol soluble proteins, but 
rarely detected in organelles or membrane proteins, which suggests that only soluble 
proteins can be degraded through CMA. A chaperone, heat shock cognate 70 kDa 
protein (Hsc70), can recognize substrates bearing CMA motifs in the cytosol, and this 
recognition facilitates the delivery of substrates to the lysosomal membrane for binding 
to the cytosolic tail of lysosome-associated membrane protein 2 (LAMP-2A)183. Each 
substrate must bind to LAMP-2A for lysosomal translocation to take place, and so it was 
thought likely that the level of LAMP-2A at the lysosomal membrane would be CMA 
rate-limiting. This was confirmed by altering the transcriptional expression or by 
mediating the degradation and lysosomal distribution187. The binding of substrates to 
the surface of the lysosome drives the multimerization of LAMP-2A into a translocation 
complex, and with the assistance of Hsc70, the substrates are imported into the 
lysosome and then rapidly degraded. Furthermore, functional assays indicate that the 
CMA pathway promotes antigen presentation of cytoplasmic peptides onto MHC class II 
molecules in professional APCs177.  
Macroautophagy is the best genetically characterized catabolic mechanism by which 
eukaryotic cells adjust their biomass, remove long-lived proteins, or eliminate aged or 
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damaged organelles188. A potential role for macroautophagy in endogenous antigen 
loading has been intensively investigated in different in vitro systems167, 169, 176, 189. The 
focus of this study is the role macroautophagy plays in mTECs during negative selection. 
The molecular mechanisms of macroautophagy, its physiological functions, and role in 
antigen presentation will be discussed in the following paragraphs. 
 
 
Graphic 3. Three different types of autophagic pathways in mammalian cells. (a) In 
microautophagy, intracellular materials are directly delivered into lysosomes for degradation via 
lysosomal membrane invaginations. (b) In chaperone mediated autophagy (CMA), substrate 
proteins are recognized by Hsc70, subsequently imported to lysosome by binding of LAMP-2A 
and rapidly degraded in there. (c) Macroautophagy is involved in the delivery of their engulfed 
cytoplasmic components to lysosomes for degradation. 
1.4 Macroautophagy – process, physiological functions, and role in endogenous 
antigen loading routes 
Macroautophagy (hereafter referred to as autophagy) is an evolutionarily conserved 
bulk degradation process for cytosolic proteins that involves the delivery of double 
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membrane sequestered cytoplasmic vesicles to the lysosome190. This process was first 
identified in resting rat hepatocytes in response to metabolic stress, such as starvation, 
and glucagon withdrawal191, 192. 
1.4.1 The biology of autophagy 
In general, compared to normal conditions, cellular antophagic activity is markedly 
upregulated by numerous stimuli, such as nutrient starvation, physiological stress, 
pharmacological agents (rapamycin, chloroquine), or innate immune signals193, 194. 
Autophagy initiates when mammalian target of rapamycin (mTOR) is inhibited by 
nutrient starvation, which results in translocation of the ULK/Atg1 kinase complex (as 
mTOR substrate) from the cytosol to certain domains of the ER. The class III 
phosphatidylinositol-3-OH kinase (PI(3)K) complex is then recruited, as well as other 
related effectors195, to trigger the initiation of an isolated membrane or ‘phagophore’, 
which contains a portion of cytoplasm from the cytosol. Consequently, the isolated 
membrane in association with other autophagy-related complexes elongates and 
engulfs cytoplasmic constituents, such as organelles or aggregated proteins, to become 
an enclosed double membrane structure known as the autophagosome. Finally, the 
outer membrane of the autophagosome fuses with a late endosome and/or lysosome to 
form a structure called the amphisome or autolysosome. Lysosomal hydrolytic enzymes 
then degrade the sequestered contents of the autophagosome together with its inner 
membrane189 and the degraded products are recycled196 (Graphic 4). 
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Graphic 4. The process of macroautophagy. (a) An isolated membrane engulfs a portion of 
cytoplasmic component, including ubiquitinylated protein aggregates or damaged organelles, (b) 
and the ‘phagophore’ further elongates with association of the antophagy-related complex (c) to 
form an enclosed double-membrane vesicle as autophagosome. (d) Subsequently, the outer 
membrane of the autophagosome fuses with a lysosome/late endosome to form autolysosome 
or amphisome; (e) the sequestered contents of autophagosome as well as the inner 
autophagosomal membrane are degraded.  
The membrane dynamics of autophagosome formation are not fully understood. As a 
highly conserved process, autophagy-associated proteins coded by autophagy-related 
genes (Atg) are highly homologous from yeast to mammals197. Products of these genes 
have been isolated and well-characterized. Most of them are involved in two specialized 
ubiquitin-like modification systems that are required for elongation and formation of the 
autophagosome in mammals (Graphic 5). One is the autophagy-related gene 12 
(Atg12)-Atg5 conjugation system, which is activated by Atg7 (E1-like) and Atg10 (E2-
like). It makes the carboxyl terminus of Atg12 conjugating to Atg5 as a dimeric complex 
which functions together with Atg16 to generate the precursor of autophagosome198. 
The other system is the Atg8 (LC3, GATE16, and GABARAP as mammalian homologs) 
conjugation system199. This process initiates when the carboxyl terminal region of 
proLC3 is cleaved by Atg4B after translation. It makes the carboxyl terminal Gly of 
proLC3 to form LC3-I (the cytosolic form)200. With the assistance of Atg7 and Atg3 (E2-
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like), LC3-I is covalently coupled to the phospholipid phosphatidylethanolamine (PE) via 
its carboxyl terminus to form the ubiquitin-like LC3-II (the membrane form), which can 
further incorporate into the newly synthesized outer and inner membrane of the 
autophagosome201. Consequently, generation of LC3-II has been viewed as the 
hallmark of autophagy, and can be evaluated biochemically (by measuring the level of 
LC3-II) or microscopically (by observing the localization pattern of fluorescently tagged 
LC3, as in GFP-LC3 mice)193. Formation of the autolysosome (the vesicle formed from 
the fusion of autophagosome and lysosome) results in rapid degradation of the contents, 
the inner membrane, and associated LC3-II, mediated by lysosomal proteases. LC3-II 
located on the outer membrane of the autophagosome is then cleaved by Atg4B and 
restored to LC3-I for further autophagosome formation202.  
 
Graphic 5. Two ubiquitin-like conjugation systems involved in elongation and shape of 
autophagosome in mammals. 
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1.4.2 Physiological roles of autophagy in mammals 
Autophagy plays a variety of roles in physiological processes in eukaryotic cells203-205. 
Autophagy occurs at low basal levels; however, it can be rapidly upregulated as an 
adaptive catabolic process in response to metabolic stress179, 193. It maintains cell 
homeostasis by turning over long-lived proteins and organelles, getting rid of toxic 
aggregated proteins, and eliminating damaged cytoplasmic components during stress 
or growth factor deprivation. Autophagy is activated in most cells to supply nutrients for 
essential anabolic needs under conditions of nutrient deprivation. During neonatal 
starvation in mice, carbohydrate and lipid reserves undergo autophagic degradation and 
are used as an energy source to survive; Atg5-deficient neonatal mice die within one 
day of starvation206.    
The broad spectrum of autophagy function is intricately linked to a wide range of healthy 
or pathological states207, 208. It has been speculated that autophagy may play a role in 
the prevention of autoimmunity and inflammatory disorders. Normal recycling of 
cytoplasmic contents, particularly in neural cells, via the autophagy pathway protects 
against the development of neurodegenerative disorders. By contrast, neural cell-
specific Atg5 or Atg7 knockout mice accumulate abnormal intracellular proteins that 
form aggregates207, 209.  
Autophagy is essential for cellular homeostasis and functional maintenance as a pro-
survival mechanism during nutrient deprivation206. The crucial role autophagy plays in T-
lymphocyte development and function has been demonstrated by generating 
autophagy-deficient lymphocytes in irradiated recipients reconstituted with Atg5-/- fetal 
hematopoietic progenitor cells. CD4 and CD8 T-cells in Atg5-/- chimeras failed to 
undergo efficient TCR-induced proliferation; furthermore, Atg5-/- CD8 T-cells displayed 
increased cell death compared to wild-type (WT) littermates210. Autophagy also plays a 
role in B-cell development, mainly by regulating the development and survival of pre-B 
and B-1a cell subsets211. 
Autophagy contributes to the function of multiple aspects of both the innate and the 
adaptive immune response. In addition to degrading endogenous substrates, a selective 
36 
 
form of autophagy, known as xenophagy, contributes to the degradation of intracellular 
pathogens, including viruses, parasites, and bacteria212-215. Gutierrez et al. showed that 
inducing autophagy by treating macrophages with IFN-γ could overcome the block in 
phagolysosomal maturation that occurs during mycobacterial infection216, which 
indicates that the autophagy pathway represents an efficient strategy for controlling 
intracellular pathogens. It has also been shown that the autophagic machinery of 
plasmacytoid DCs (pDCs) mediates delivery of viral RNA to endosomal toll-like 
receptors (TLRs), inducing the production of type I IFNs via TLR7 signaling215.   
The role of autophagy in immunity is not limited to the elimination of intracellular 
pathogens. It may also be a mechanism for antigen presentation. Indeed, data from 
recent studies imply a role for autophagy in regulating MHC class I-mediated cross-
presentation of exogenous antigens217. Treatment with an inducer of autophagy 
enhances antigen cross-presentation218. Conversely, cross-presentation of antigen is 
significantly reduced by an autophagy inhibitor219. 
1.4.3 Autophagy and MHC class II antigen presentation 
Recent studies reveal that autophagy is a potential mechanism for MHC class II 
endogenous antigen presentation. For example, presentation of cytosolic and nuclear 
antigens increases, on average by 50%, when cultured B-cell lines are starved to 
induce autophagy. For some individual ligands, the increase can exceed 130%, 
whereas membrane-bound antigen presentation is barely affected167. In contrast with 
proteasome-mediated antigen processing for coupling to MHC class I molecules, which 
favors proteins with a shorter half-life (e.g., defective ribosomal products (DRiPs)), 
autophagy substrates tend to be longer-lived, aggregated forms of ubiquitin-like 
proteins209. Currently, the ubiquitin-binding protein p62/SQSTM1 and autophagy-linked 
FYVE-domain-containing protein (Alfy) are the leading candidates for selective 
recognition of and targeting to the autophagy machinery. The p62 protein possesses 
both an LC3 recognition sequence and a ubiquitin-binding association (UBA) domain, 
which suggests that it serves as an adaptor linking polyubiquitinated substrates to 
Atg8/LC3 via UBA and LC3 interacting domains (LIRs) for autophagy-mediated 
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degradation220, 221. Alfy also colocalizes with autophagic marker LC3-II and ubiquitin-
containing protein aggregates222, suggesting Alfy may be a regulator for selective 
autophagy by targeting certain aggregated cytosolic proteins to autophagosomes. In 
addition, a nuclear factor E2-related factor 2 (Nrf2)-dependent stress response pathway 
has been implicated in the selection of aggregated proteins as substrates for 
autophagy223. Similarly, the pro-apoptotic factor NIX is used by mitochondria to mediate 
mitophagy as another form of selective autophagosomal degradation224, 225.   
Münz and colleagues initially showed that blocking autophagy inhibits endogenous 
MHC class II processing specifically for an EBV nuclear antigen, which results in 
decreased recognition by CD4 T-cells with specificity for this antigen226. Many other 
studies demonstrate that autophagy indeed contributes to the shuttling of intracellular 
antigens into the MHC class II loading pathway167, 169, 170, 227. However, it has not yet 
been clarified whether autophagy is a general and efficient pathway for MHC class II 
presentation of endogenous antigens. A later study by Münz’s team189 indicates that 
there is a substantial level of steady-state autophagy was continuously turned over in a 
variety of constitutive MHC class II-positive APCs, such as B-cell lines, monocytes, and 
DCs, and also in epithelial cell lines with IFN-γ-induced MHC class II expression. By 
observing GFP-LC3, they found that the autophagosome is frequently fused with MIIC, 
indicating that autophagosome cargo does indeed gain access to MHC class II for 
antigen presentation. It also raises the question of whether the multivesicular 
compartment formed by fusing of autophagosome and MIIC contains both MHC class II 
molecules and LC3 on its internal membranes. More importantly, targeting influenza 
matrix protein 1 (MP1) to the autophagosome as an LC3 fusion protein results in 
enhanced MHC class II presentation of MP1 and specific CD4 T-cell recognition, which 
suggests that autophagy constitutively and efficiently delivers cytosolic antigens for 
MHC class II presentation.  
In accordance with these findings, it is plausible that autophagy-mediated MHC class II 
presentation of self-antigen plays a crucial role during thymic CD4 T-cell education. As 
the only non-hematopoietic cell type that constitutively expresses MHC class II 
molecules, TEC displays remarkably poor phagocytic activity75, which suggests there is 
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an alternative MHC class II loading pathway. Analysis of GFP-LC3 mice indicates that 
starvation can significantly enhance autophagic activity in most tissues, including 
pancreas and muscle, which confirms the role of autophagy in the maintenance of 
energy homeostasis by recycling cytoplasmic components as a nutrient source193. 
However, in some other tissues, including thymic and lens epithelial cells, a higher 
basal level of autophagic activity, even in nutrient-rich conditions, is observed, and 
suggests that the number of autophagosomes in the TE may be among the highest in 
non-starved tissues. Indeed, roughly 70% of cTECs and 5–10% of mTECs contain high 
numbers of autophagosomes228. Furthermore, in line with the potential contribution of 
autophagy to the generation of MHC class II-bound peptides for T-cell selection, 
autophagosomes have been found fused with MIIC in thymic cryosections, with co-
localization of LC3 with H2-DM-positive compartments229. This fusion strongly suggests 
that self-peptides expressed in the thymus can be shuttled into MHC class II molecules 
via the autophagy pathway in both cTECs for positive selection and mTECs for negative 
selection.  
The most direct evidence228 for the involvement of autophagy in positive selection of 
MHC class II-restricted TCRs in the TE was obtained in chimeras transplanted with 
autophagy-deficient thymi. This study showed that positive selection was impaired for 
some specific CD4 T-cells but enhanced for others, implying the alternation of the 
composition of MHC class II-bound peptides on cTECs occurs in the absence of 
autophagy in thymic epithelium, whereas selection of MHC class I-restricted TCRs was 
apparently unaffected. A similar setting was used to address whether the polyclonal T-
cell repertoire selected by Atg5-/- TECs is self-tolerant; athymic nude mice were 
transplanted with either Atg5-/- or WT embryonic thymi. Only the recipients of Atg5-/- 
grafts started to lose weight 6 weeks post-transplantation, and compared to the controls 
had an increased number of activated peripheral CD4 T-cells. Inspection of internal 
organs revealed massive inflammatory infiltrates in the colon, liver, uterus, and lymph 
nodes. In line with autophagy-deficient TE perturbing the generation of selecting MHC II 
ligands, secondary transfer of the CD4 T-cells from diseased mice to WT recipient 
recapitulated all the autoimmune symptoms. However, it remains unclear whether the 
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escape of these autoreactive CD4 T-cells results from a lack of negative selection or the 
failure of deviation into Tregs, or is in fact lymphopenia caused by impaired positive 
selection. 
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2. Aim of the thesis 
A growing number of studies have demonstrated that mTECs mediate central CD4 T-
cell tolerance through direct presentation of endogenously expressed self-antigens230-232. 
As the only non-hematopoietic cell type that expresses MHC II molecules, TEC shows 
remarkably poor phagocytic activity75. Therefore, the pathway of MHC class II antigen 
loading in mTECs for negative selection of thymic CD4+ T-cell remains poorly defined. 
Observations of colocalization of LC3 with MIIC compartments in the thymus229 along 
with high numbers of autophagosomes presented in roughly 70% of cTECs and 5–10% 
of mTECs indicate that autophagy may shuttle intracellular materials into the MHC II 
loading pathway. A previous study from our lab further demonstrated that interference 
with autophagy specifically in TECs led to altered selection of certain MHC II restricted 
T-cells and resulted in multi-organ inflammatory infiltration228. Taken together, these 
results strongly suggest a contribution of autophagy for T-cell selection by focusing the 
MHC II/peptide repertoire of TECs on their intracellular milieu. However, it is not yet 
clear whether autophagy in mTECs contributes to induce central CD4 T-cell tolerance. 
Here, we aimed to address this issue by generating transgenic mice that express a 
model antigen (human C-reactive protein, hCRP) specifically targeted to 
autophagosomes in Aire+ mTECs and by examining the fate of DEP-specific CD4+ T-
cells.  
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3. Results 
3.1 Cloning and functional evaluation of constructs targeting a model-antigen to 
autophagosomes 
To obtain an autophagy substrate, an antigen was designed to deliberately introduce to 
autophagy degradation system. A tripartite hybrid protein was cloned (Figure1a). Briefly, 
a N-terminal fused Enhanced Green Fluorescent Protein (eGFP) was used as a reporter 
followed by a part of human C-reactive protein (hCRP) containing an epitope 
recognized by DEP specific TCR. LC3 was then fused in the C terminal of this fusion 
protein for autophagosome targeting (hereafter referred as GCL). During the process of 
autophagosome formation, the C-terminal region of proLC3 is cleaved, which exposes 
Gly120 to form LC3-I. Then the Gly120 site is conjugated to phosphatidylethanolamine 
(PE) for incorporation on both outer and inner membrane of autophagosome as LC3-
II199(Figure 1b). We also generated another construct with non-targeting to 
autophagosome by introducing a point mutant at position 120 of LC3. This mutation 
makes the residue change from Gly to Ala201 (hereafter referred as GCLG120A) (Figure 
1a).  
In order to visualize the targeting of these two constructs, HEK 293T cells were 
transfected with either GCL or GCLG120A plasmid. Localization of hybrid proteins was 
monitored by fluorescence microscopy to examine whether antigen was fused with 
autophagosome or not. In Figure 1c, GFP distribution was even in the cytoplasm of both 
transfected cells that were cultured in full medium. However, GFP+ punctae was only 
found in cells expressing GCL-vector in starvation medium supplemented with 
rapamycin (mTOR inhibitor which results in autophagy initiation), and no segregation of 
GFP dots could be observed in GCLG120A-expressing cells under the same condition.     
 
 
 
42 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Targeting pattern of GCL and GCLG120A.  (a) Construct scheme of the GCL and 
GCLG120A. (b) Schematic illustration of GCL targeting to autophagosome. GCL fusion proteins 
incorporate on both outer and inner membrane of autophagosomes via conjugation of LC3 to 
phosphatidylethanolamine (PE). (c) Assessment of localization of expressed proteins. HEK 
293T cells were transfected with expression vectors encoding for GCL and GCLG120A and then 
cultured in either full medium or starvation medium with rapamycin for 20h, the localization of 
expressed proteins was monitored by fluorescence microscopy. Scale bars indicate ×20µm. 
Panels show representative cells from one out of 2 independent experiments. 
3.2 Generation and characterization of mTEC-specific GCL and GCLG120A 
transgenic mice 
To explore the role autophagy plays in mTECs to induce central CD4 T-cell tolerance, 
we generated transgenic mice expressing this fusion antigen specifically in mTECs. 
Two bacterial artificial chromosome (BAC) constructs containing 152kb upstream and 
43 
 
58kb downstream flanking regions of AIRE locus were cloned, along with the AIRE start 
codon replaced by an open reading frame encoding GCL or GCLG120A as downstream of 
the β glubin intron (Figure 2a). By microinjection of these two constructs into fertilized 
eggs, seven or nine individual transgenic founders for the GCL or GCLG120A constructs 
were generated, respectively. Due to introducing a restriction enzyme cutting site of Nru 
I into GCLG120A, between GCL and GCLG120A could be easily distinguished (shown in 
Supplementary Figure 1).    
First, the expression pattern of GCL or GCLG120A was examined. mRNA of various 
thymic stromal cell subsets from each founder was purified. The relative expression 
level of the transgene was quantified by real-time PCR (qPCR). The results indicated 
that mRNA expression of GCL or GCLG120A in each founder was exclusively restricted 
into mTEC subpopulation, mainly in mTEChi (phenotype as CD45-Epcam+Ly51-
MHCIIhiCD80hi), partial expressed in mTEClo (phenotype as CD45-Epcam+Ly51-
MHCIIloCD80lo), rarely in cTEC (phenotype as CD45-Epcam-Ly51+) as well as DC 
(phenotype as CD45+CD11C+) (Supplementary Figure 2 and Figure 2b). Moreover, 
mRNA level of transgene expressing in mTECs varied among these founders 
(Supplementary Figure 2). To ascertain the transgene expression is truly in mTEC 
subset, the expression of AIRE gene was also analyzed. AIRE gene could be found 
highly expressing in mTEChi and less in mTEClo subpopulation, and hardly be detected 
in cTEC and DC subsets (Supplementary Figure 3 and Figure 2c).   
Next, we aimed to figure out whether the expression of GCL or GCLG120A proteins could 
be measured by quantifying GFP signal via FACS analysis. As we expected, GFP 
fluorescence signal became a mTEC-specific marker and varied from one transgenic 
line to another, while no signal was detected in either cTECs or DCs (Supplementary 
Figure 4a, 4b and Figure 2d). Furthermore, we found the higher transgenic mRNA level 
in mTECs corresponded to the stronger GFP signal, and the signal could be detected 
only in mTECs with a relatively higher expression level.  
Based on qPCR data and FACS-analyses of GFP signal, a matched pair of transgenic 
lines was chosen for further investigation. Compared to the other transgenic founders, 
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these two mouse strains (referred to as Aire-GCL and Aire-GCLG120A) expressed a 
relatively comparable, intermediate level of GCL or GCLG120A in mTEC
hi and mTEClo 
subpopulations (Figure 2b and 2d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  2. Generation of mTEC-specific GCL and GCLG120A transgenic mice and analysis 
of transgene expression.  (a) Scheme of the Aire-GCL and Aire-GCLG120A BAC transgenic 
constructs to drive a specific expression of the fusion protein in mTECs (pA=poly-adenylation 
signal). (b) Quantitative analysis of transgenic mRNA expression. Different stromal cell types 
(cTEC, mTEChi, mTEClo and DC) were isolated from 2-week-old Aire-GCL or Aire-GCLG120A 
mice and transgenic mRNA level was assessed by qPCR. (c) The graph showed the relative 
expression of AIRE mRNA in respective stromal cells from 2-week-old Aire-GCL, Aire-GCLG120A 
mice or WT littermates. Values from (b) and (c) are normalized to expression in mTEChi from 
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Aire-GCL mice and indicated the mean±standard deviation from 3 independent experiments 
with pooled material from at least 4 thymi. None of the differences between individual subsets 
from Aire-GCL and Aire-GCLG120A mice were statistically significant. (d) Transgenic proteins 
expression by different thymic stromal cell populations (mTEC, cTEC and DC) of WT (gray), 
Aire-GCL (blue) or Aire-GCLG120A (red) thymi was determined by FACS analysis. Data are 
representative of 2 independent experiments, each with 5 mice.   
3.3 Different direct presentation in GCL and GCLG120A mTECs 
3.3.1 GCL but not GCLG120A is directly presented by mTECs  
So far, our experiments had established the mice in which the expressing transgene 
was restricted into the mTEC subset. To address whether this expression pattern 
induces direct presentation by mTECs, or the mTEC-derived antigen is eventually 
processed and indirectly presented by neighboring DCs, we isolated mTECs and DCs 
from both lines separately and measured the capacity of APCs to activate hCRP89-101-
specific T hybridoma cells with an NFAT-driven GFP reporter. 
Upon 20h-incubation with Aire-GCL mTECs, 16% of hCRP89-101-specific T hybridoma 
cells turned into GFP+ (see in Figure 3a). However, the same observation could not be 
found in T cell hybridomas stimulated by mTECs from Aire-GCLG120A mice, only a weak 
response was elicited (P=0.008, vs. WT controls; Figure 3b)). In contrast, the 
percentage of GFP+ cells stimulated by DCs from either Aire-GCL or Aire-GCLG120A was 
not as high as stimulated by Aire-GCL mTECs, the response only maintained a 
marginal level as compared with WT DCs (P=0.048 and P=0.013, respectively; Figure 
3b). Taken together, for GCL (the autophagy substrate), its antigen presentation 
mediated by mTECs is much more efficient than the variant GCLG120A that express in a 
comparable level yet has one AA exchange to block the autophagosome targeting. 
3.3.2 Mutation does not impact MHC class II expression and function in Aire-
GCLG120A mTECs  
Since the weaker T cell stimulation capacity of Aire-GCLG120A mTECs was measured as 
comparing with Aire-GCL mTECs, it raises the concern that the point mutation which 
abolishes autophagosome targeting might result in the alteration of mTEC function, 
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such as impaired MHC class II expression, and further leads to weak capacity on 
peptide presentation.  
In order to address this issue, the surface MHC class II expression of mTECs from Aire-
GCL, Aire-GCLG120A mice and WT littermates was examined. A similar expression level 
of MHC class II on mTECs was observed (Figure 3c). Furthermore, mTECs from 
indicated groups were purified and cultured with T cell hybridomas to analyze their 
peptide presentation capacity in the presence of CRP peptides (6µg/ml). In Figure 3d, 
up to 80% of DEP T hybridoma cells recognition was activated by Aire-GCL or Aire-
GCLG120A mTECs with peptide pulsed and the percentage of increased GFP
+ cells had 
no significant difference compared to WT mTECs with peptides (P=0.1283 and 
P=0.0709, respectively).  
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Figure  3. Characterization of antigen presentation capacity of Aire-GCL mTECs.  (a) 
Assessment of antigen presentation capacity in vitro. Ex-vivo isolated mTECs from 5-week-old 
WT, Aire-GCL and Aire-GCLG120A mice were cultured with NFAT-GFP reporter hybridoma cells 
expressing hCRP89-101-specific DEP-TCR. After 20h, GFP expression of T hybridoma cells was 
measured by FACS analysis. The bar diagram depicts the frequency of GFP+ hybridoma cells 
stimulated by mTEC from each group. (b) Summary of the percentage of T hybridoma cells with 
GFP-fluorescence stimulated by mTEC (black bars) or DC (white bars) from indicated groups. (c) 
Freshly mTECs of Aire-GCL and Aire-GCLG120A thymi were isolated and MHC II expression level 
was measured by FACS. Values are representative from one out of two independent 
experiments with pooled material from at least 6 thymi. (d) Assessment of peptide presentation 
in vitro. The bar diagram shows the percentage of GFP+ hybridoma cells stimulated by Ex-vivo 
isolated mTEC from indicated mice in the presence of 6µg/ml CRP peptide. Values from 
(a),(b),(d) are representative of 3 independent experiments with pooled material from at least 6 
thymi. ( n.s.= not significant.) 
3.4 mTECs directly present GCL, but not GCLG120A, for negative selection 
3.4.1 A similar ‘late’ negative selection displays in both double transgenic strains  
To assess the consequence of distinct antigen presentation patterns of mTECs in both 
lines on central tolerance of CD4+ T-cells, Aire-GCL and Aire-GCLG120A mice were bred 
with DEP TCR-tg mice bearing a TCR recognizing epitope CRP89-101
232. In Figure 4a 
and 4b, compared to DEP TCR transgenic mice as controls, both double transgenic 
mice showed a similar extent of ‘late’ negative selection which self-reactive T-cell 
deletion occurred at the CD4 SP stage. It correlated with a relative and absolute number 
reduction of CD4 SP thymocytes to roughly 20%. Among these remaining CD4 SP 
thymocytes, expression of α chain and ß chain of DEP specific TCR had a considerable 
downregulation. In contrast, a statistically reduction in the absolute numbers of Tregs 
was found (Figure 4c). These data indicate that immune tolerance of DEP TCR-specific 
thymocytes predominantly operates via T-cell deletion in both lines. 
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Figure  4. Negative selection of hCRP89-101 specific CD4
+ T-cells in double transgenic mice.  
(a) CD4+ T-cell development in 4- to 5-week-old DEP single transgenic mice, Aire-GCL×DEP 
and Aire-GCLG120A×DEP double transgenic mice. The plots depict that the average percentage ± 
stdev of CD4 SP profiles (upper row) and of DEP-TCR+ cells (Vα11+Vβ5.1+) among gated CD4 
SP thymocytes (lower row). (b) The bar diagram shows the percentage and absolute numbers 
of CD4 SP Vα11+Vβ5.1+ cells among total thymocytes in (a). Data in (a) and (b) are from ≥10 
mice per genotype. (c) Summary of the absolute numbers of CD4 SP Vα11+Vβ5.1+ Foxp3+ cells 
among total thymocytes. Data in (c) are from at least 5 mice per genotype. (P values are 
indicated) 
3.4.2 Antigen exclusively expressed in thymic epithelium is sufficient to mediate 
negative selection  
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Based on observations in Figure 4b shown distinct antigen presentation patterns of 
Aire-GCL or Aire-GCLG120A mTECs resulted in the similar extent of DEP T-cell deletion 
in corresponding double transgenic mice, we therefore hypothesize whether different 
antigen presentation routes contribute to T-cell deletion in each line.   
Briefly, to determine whether antigen exclusively expressed in thymic epithelium is 
available and sufficient to mediate a comparable extent of negative selection in Aire-
GCL and Aire-GCLG120A mice. Irradiated Aire-GCL, Aire-GCLG120A or WT recipients were 
reconstituted with DEP TCR-tg bone marrow (BM) for four to five weeks and T-cell 
development was analyzed. As we expected, WT recipients which received DEP BM 
had a normal percentage of DEP TCR-specific CD4 T-cells (in Figure 5a and 5c), 
indicating positive selection was not impaired. However, when DEP BM was transferred 
into either Aire-GCL or Aire-GCLG120A mice, most of DEP TCR-specific CD4 T-cells were 
deleted due to recognized as self-reactive thymocytes, which represented the similar 
extent of negative selection as the respective double transgenic mice in Figure 4.  
3.4.3 Direct presentation via GCL mTECs versus indirect presentation by 
GCLG120A DCs is essential for clonal deletion 
To understand the contribution of DC versus mTEC in CD4 T-cell tolerance induction, 
different BM chimeras were generated by removing DC from the system. To this end, 
mice that carried diphtheria toxin α chain (DTA) under the control of a loxP-flanked stop 
cassette in the ubiquitously expressed ROSA26 locus were utilized and crossed to 
CD11c-Cre mice, which led to the physical ablation of DC (∆DC)233. And then the BM 
from DEP TCR-tg ∆DC were transferred into irradiated Aire-GCL, Aire-GCLG120A or WT 
mice, which abolished the ability of DC to present antigen in the thymus. Results 
showed the percentage of DEP CD4+ T-cells in Aire-GCL mice receiving BM from ∆DC 
had no change compared to mice injected with DC-sufficient BM. In contrast to efficient 
CD4+ T-cell deletion in Aire-GCLG120A mice with transferring of DEP TCR-tg BM, there 
was a significant enlargement of CD4+ T-cells in mice receiving DEP TCR-tg ∆DC BM 
(P<0.001; Figure 5b and 5c). However, this DEP specific CD4 T-cell rescue caused by a 
lack of DCs is not complete. Comparing with WT controls, there was still a significant 
decreased percentage of CD4+ T-cells in Aire-GCLG120A mice receiving DEP TCR-tg 
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∆DC BM (P=0.0013; Figure 5b and 5c), which suggests there is the existence of 
autonomous presenting mTEC-induced negative selection in Aire-GCLG120A mice. 
Collectively, these findings suggest distinct antigen presentation routes operate in Aire-
GCL and Aire-GCLG120A mice for induction of CD4
+ T cell tolerance, which means 
autophagosome-targeted GCL is capable to be directly presented by mTECs and this 
direct presentation is sufficient to induce a robust negative selection. While in Aire-
GCLG120A mice, cross presentation mediated by DCs seems to be the main mode to 
induce an efficient clonal deletion.      
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Figure  5. mTECs directly presenting GCL, but not GCLG120A, are essential for negative 
selection.  (a) CD4+ T-cell development in WT, Aire-GCL or Aire-GCLG120A recipients 4-5 weeks 
after irradiation and reconstitution with DEP bone marrow. The average frequencies of CD4 SP 
T-cells are shown (± stdev) in upper row and of DEP-TCR+ cells (Vα11+Vβ5.1+) among gated 
CD4 SP thymocytes are depicted (± stdev) in lower row. Values are representative of at least 10 
chimeras per group. (b) CD4+ T-cell development in WT, Aire-GCL or Aire-GCLG120A recipients 
of DEP×∆DC bone marrow cells were analyzed after 4-5 weeks reconstitution.  Dot plots show 
the average frequency± stdev of CD4 SP T-cells (upper row) and of DEP-TCR+ cells 
(Vα11+Vβ5.1+) among gated CD4 SP thymocytes (lower row). Data are representative of at 
least 9 chimeras from each group. (c) Summary of the percentage of CD4 SP Vα11+Vβ5.1+ cells 
among total thymocytes in (a) and (b). (P values are indicated; n.s.= not significant.) 
3.5 Direct antigen presentation by Aire-GCL mTECs is autophagy-dependent 
3.5.1 Autophagy deficiency impairs negative selection mediated by direct 
pathway  
To address the role of autophagy played on mTECs in direct presentation of intracellular 
antigens, different thymus chimeras with interference of autophagy in TECs were 
generated. Irradiated WT mice that were reconstituted with DEP-tg MHC II-/- 234 bone 
marrow were used as the recipients of thymus grafts. In this system, it abolished indirect 
antigen presentation of DCs due to the disrupted MHC class II expression on DCs. In 
Figure 6a and 6c, an unimpaired, efficient positive selection of DEP TCR-specific 
thymocytes was shown in non-antigen expressing chimeras transplanted with Atg5 +/- or 
Atg5 -/- thymi, which consists with our previous reports228. When the grafted epithelium 
expressed endogenous GCL and was autophagy-sufficient, negative selection occurred 
and the percentage of remained thymocytes was less than 20% (Figure 6b and 6c). A 
similar extent of T-cell deletion as the setting described in Figure 5b and 5c was 
observed, and it is convinced that direct presentation mediated by AIRE-GCL mTECs is 
sufficient to induce negative selection. In contrast, when the transplanted Aire-GCL 
epithelium was autophagy-deficient, a significant reduction of DEP T-cell deletion could 
be observed (P<0.001; Figure 6b and 6c). However, an incomplete DEP specific CD4 T-
cell deletion still existed in chimeras grafted Aire-GCL thymi compared with WT controls 
under the autophagy-deficient condition (P<0.001; Figure 6b and 6c). Collectively, 
negative selection mediated by direct presentation in AIRE-GCL mTECs at least in part 
depends on the autophagy pathway. Additionally, the pathway that mediates direct 
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presentation by mTECs observed in Aire-GCLG120A mice (Figure 5c) is autophagy-
independent, since there was no difference in the extent of deleted DEP T-cells 
between Atg5-sufficient and Atg5-deficient Aire-GCLG120A grafted thymi (P=0.1749; 
Supplementary Figure 5). 
 
 
 
 
 
 
 
 
Figure  6. Negative selection mediated by direct presentation in Aire-GCL mTECs is 
partly autophagy-dependent.  (a) Autophagy deficiency does not impact positive selection of 
DEP cells. CD4+ T-cell development in Atg5+/- or Atg5-/- thymi lobes transplanted into DEP×MHC 
II-/- recipients measured after 4-6 weeks reconstitution. The dot plots depict the average 
frequency of CD4 SP T-cells are shown (± stdev) in upper row and of DEP-TCR+ cells 
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(Vα11+Vβ5.1+) among gated CD4 SP thymocytes are depicted (± stdev) in lower row. Values 
are representative of at least 11 chimeras per group. (b) Defective negative selection of DEP 
cells is shown in Aire-GCL thymi with autophagy deficiency. Histograms show staining of CD4+ 
SP T-cells for DEP-TCR from Aire-GCL×Atg5+/- or Aire-GCL×Atg5-/- thymi lobes 4-6 weeks after 
transplantation into DEP×MHC II-/- recipients. Numbers in the dot plots indicate the average 
frequency ((± stdev) of CD4 SP T-cells (upper row) and of DEP-TCR+ cells (Vα11+Vβ5.1+) 
among gated CD4 SP thymocytes (lower row). Data are representative of at least 13 chimeras 
in each group. (c) Summary of the frequencies and absolute numbers of CD4 SP Vα11+Vβ5.1+ 
cells among total thymocytes in (a) and (b). (P values are indicated; n.s.= not significant.) 
3.5.2 Autophagy deficiency impairs the endogenous antigen presentation  
In Figure 6b and 6c, a significant reduction on the percentage of deleted thymocytes 
could be found in DEP MHC II-/- recipients transplanted with Aire-GCL autophagy-
deficient lobes, which suggests negative selection mediated by Aire-GCL mTECs 
depends on autophagy pathway. As a result, the issue of whether direct presentation 
capacity of Aire-GCL mTECs would be impaired when the autophagy pathway was 
interfered is investigated. mTECs from thymus chimeras described in Figure 6 were 
isolated and used to stimulate T cell hybridomas. In Figure 7a, although the percentage 
of GFP+ hybridomas stimulated by Aire-GCL Atg5 +/- mTECs from grafted lobes was not 
as high as those stimulated by Aire-GCL mTECs described in Figure 3a, it still 
generated 6% GFP+ cells from the co-culture system, a statistically significant response 
was induced by Aire-GCL mTECs with autophagy-sufficient compared to mTECs with 
GCL-expressing, but autophagy-deficient (P=0.0084; as shown in Figure 7b). Thus, 
these data suggest that the defective efficiency on direct presentation of Aire-GCL 
mTECs caused by interfering with autophagy is responsible for the severe impaired 
negative selection shown in Figure 6b and 6c. 
To investigate the possibility of impaired peptide presentation capacity in Aire-GCL 
mTECs resulted from Atg5 deficiency, hCRP89-101-specific T hybridoma cells were 
cultured with mTECs from GCL-expressing Atg5+/- or Atg5-/- grafted lobes in the 
presence of CRP peptide (6µg/ml). Data indicated that no matter autophagy pathway 
was interfered or not, Aire-GCL mTECs induced a similar level of GFP+ hybridomas 
upon culturing with peptides (see Figure 7c). At the same time, we observed the MHC II 
expression was not affected when Atg5 was deficient in mTECs. A slightly higher, but 
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comparable level of MHC II was expressed on mTECs from Aire-GCL Atg5 +/- or Aire-
GCL Atg5 -/- lobes compared with mTECs from WT littermates (Figure 7d).  
 
 
 
 
 
 
Figure  7. Characterization of antigen presentation by Aire-GCL mTECs with interference 
of autophagy. (a) Assessment of antigen presentation capacity in vitro. Ex-vivo isolated 
mTECs from GCL-expressing Atg5+/- or Atg5-/- grafted lobes as well as WT littermates were 
cultured with NFAT-GFP reporter hybridoma cells expressing hCRP89-101-specific DEP-TCR. 
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After 20h, GFP expression of T hybridoma cells was measured by FACS analysis. Values show 
the frequency of stimulated GFP+ hybridoma cells from one out of three independent 
experiments with pooled material from ≥6 grafted lobes. (b) Summary of the percentage of 
hybridomas with GFP-fluorescence stimulated by mTECs from indicated groups. Values are 
representative of 3 independent experiments with pooled material from at least 6 grafted lobes 
(P values are indicated). (c) Assessment of peptide presentation in vitro. Values show the 
percentage of GFP+ hybridoma cells by Ex-vivo isolated mTEC from indicated groups in the 
presence of 6µg/ml hCRP peptide. (d) Freshly mTECs from indicated groups were isolated and 
MHC II expression level was measured by FACS. Values from (c) and (d) are representative 
from one out of two independent experiments with pooled material from at least 6 grafted lobes. 
3.6 A redundant role of mTECs and DCs from Aire-GCL thymi on negative 
selection 
Although direct presentation by Aire-GCL mTECs is essential for negative selection, the 
contribution of DCs in Aire-GCL system to present autophagosome-targeted GCL is still 
not clear. The investigation system used in Figure 5b highlights the crucial role of 
indirect presentation by Aire-GCLG120A DCs played on induction of negative selection. 
Additionally, the data from Figure 3b indicates the antigen presentation capacity 
between Aire-GCLG120A and Aire-GCL DCs is comparable. Thus, we are wondering if 
central tolerance in Aire-GCL mice would be affected in the presence of ‘presentation-
competent’ DCs when direct presentation by mTECs is diminished. 
To verify it, DEP MHC II sufficient mice as recipients were transplanted with Aire-GCL 
Atg5+/- or Aire-GCL Atg5-/- embryonic lobes as well as wide type littermates. In Figure 8a, 
five weeks after reconstitution, most of DEP CD4+ T-cells were positively selected and 
showed a normal percentage in either Atg5+/- or Atg5-/- transplanted lobes in which no 
antigen was expressed. However, in Aire-GCL Atg5+/- transplanted lobes roughly two 
third of DEP thymocytes were deleted, which was consistent with a strong CD4 T-cell 
deletion occurred in Aire-GCL Atg5+/- lobes transplanted into MHC II deficient DEP-Tg 
mice. In contrast, a similar extent of CD4+ T-cell deletion was achieved in DEP MHC II 
sufficient recipients even though the transplanted Aire-GCL epithelium was autophagy-
deficient (Figure 8b,c, compared Figure 6b,c). Thus, indirect presentation by DCs is 
capable to compensate autophagy-dependent direct presentation by mTECs in Aire-
GCL system. 
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Figure  8. Direct presentation by mTECs and indirect presentation by DCs in Aire-GCL 
thymus operate in parallel. (a) Analysis of thymus chimeras of interfering with autophagy in 
TECs. DEP×MHC II+/+ mice as recipients were transplanted with Atg5+/- or Atg5-/- thymi lobes, 4-
6 weeks later, DEP CD4+ T-cell development was measured. The dot plots depict the average 
frequency of CD4 SP T-cells are shown (± stdev) in upper row and of DEP-TCR+ cells 
(Vα11+Vβ5.1+) among gated CD4 SP thymocytes are depicted (± stdev) in lower row. Values 
are representative of at least 19 chimeras per group. (b) In the presence of ‘presentation-
competent’ DCs, a non-impaired DEP T-cell deletion occurs in Aire-GCL TECs with autophagy 
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deficiency. CD4+ SP T-cells for DEP-TCR from Aire-GCL×Atg5+/- or Aire-GCL×Atg5-/- thymi 
lobes 4-6 weeks after transplantation into DEP×MHC II+/+ recipients were stained and analyzed. 
The average frequency of CD4 SP T-cells are shown (± stdev) in upper row and of DEP-TCR+ 
cells (Vα11+Vβ5.1+) among gated CD4 SP thymocytes are depicted (± stdev) in lower row. 
Values are representative of at least 10 chimeras per group. (c) Summary of the frequencies 
and absolute numbers of CD4 SP Vα11+Vβ5.1+ cells among total thymocytes in (a) and (b). 
(n.s.= not significant.) 
3.7 A crucial role of autophagy-dependent direct presentation by mTECs at lower 
antigen expression level 
3.7.1 Antigen expression level in a second Aire-GCL strain 
Considering the data that much more GFP+ hybridomas were generated when 
stimulated by Aire-GCL mTECs compared to Aire-GCL DCs (Figure 3b), while these 
DCs are also capable to mediate efficient negative selection in Aire-GCL system (Figure 
8b). It arises the hypothesis that negative selection can be co-mediated via direct 
presentation by mTECs as well as indirect presentation by DCs when the amount of 
endogenous antigen expressed by mTECs exceeds the minimal requirement for 
induction of negative selection. Thus, the issue of whether DC-mediated negative 
selection depends on the amount of mTEC-expressed antigen is investigated. 
To test this hypothesis, a second Aire-GCL strain was used to perform analysis. 
Comparison of mRNA expression level indicated that a less mRNA expression of 
roughly 3-4 fold decrease was measured in mTEChi and mTEClo subpopulations from 
the second Aire-GCL strain (referred to as Aire-GCLlo) than the Aire-GCL line (Figure 
9a). The GFP fluorescent in Aire-GCLlo mTECs could not be detected, which indicates 
lower transgenic proteins were expressed (Figure 9b). 
3.7.2 Fewer antigen expression on Aire-GCLLo mTECs displays weaker antigen 
presentation capacity  
Next, we assessed antigen presentation capacity of Aire-GCLlo mTECs with lower 
antigen expression level. There are less GFP+ cells stimulated by Aire-GCLlo mTECs 
compared to Aire-GCL mTECs (1.64±0.21% vs. 12.58±3.14%)(Figure 9c). 
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In order to have a more precise comparison on direct presentation capacity of mTECs 
between Aire-GCL and Aire-GCLlo strains, a peptide titration curve was drawn to depict 
activation of T hybridoma cells when stimulated by co-cultured WT mTECs in the 
presence of different concentration (with titrated doses) of hCRP peptide. By 
comparison of Figure 9c and 9d, the percentage of stimulated T hybridoma cells by 
Aire-GCL mTECs was similar to that of WT mTECs added with 1.2µg/ml peptide 
(12.58±3.14% vs. 15.55%), while the percentage of stimulated hybridomas by Aire-
GCLlo mTECs was similar to that of WT mTECs added with 455ng/ml peptide 
(1.64±0.21% vs. 1.99%). By calculation, it was roughly a 3-fold weaker direct 
presentation capacity in Aire-GCLlo mTECs than Aire-GCL mTECs. 
 
 
 
 
 
 
Figure  9. A lower antigen expression level in Aire-GCLlo mTECs performs a weaker 
antigen presentation capacity.  (a) Expression analysis of GCL transgenic mRNA. GCL 
mRNA was isolated from purified different thymic stromal subsets defined as in Figure 2b from 
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Aire-GCL or Aire-GCLlo mice and the relative transgenic mRNA expression level was 
determined by qPCR. Values are normalized to expression in mTEChi from Aire-GCL mice and 
indicate the mean±standard deviation from 3 independent biological replicates. (b) 
Quantification of transgenic protein expression was assessed by measurement of GFP 
fluorescence in mTECs from Aire-GCLlo mice (red), WT mTECs (gray) as a negative control. 
Values are representative of 3 independent experiments with pooled cells from at least 4 thymi. 
(c) Assessment of antigen presentation capacity. Freshly isolated mTECs from Aire-GCL, Aire-
GCLlo or WT mice cultured with hCRP89-101 specific T hybridoma cells, 20h later, frequencies of 
stimulated GFP+ hybridoma cells were measured. The bar diagram shows the percentage of 
hybridomas with GFP-fluorescence stimulated by mTEC from indicated mice. Values are 
representative of 3 independent experiments with pooled cells from at least 6 thymi. (d) CRP 
peptide 1.2-fold titration standard curve was drawn by analysis of the percentage of GFP+ T 
hybridoma cells stimulated by ex vivo isolated WT mTECs (c) in the presence of different 
concentration of CRP peptide. n=1 per peptide concentrate, one of two experiments is 
represented.  
3.7.3 In Aire-GCLlo mice, mTEC performs an essential role in mediating central 
CD4+ T-cell tolerance  
Next, thymocyte development in Aire-GCLlo × DEP TCR-tg double transgenic mice was 
analyzed. Irrespective of the considerable differences on antigen expression level 
between Aire-GCLlo and Aire-GCL lines, a similar extent of negative selection was 
observed in Figure 10a and 10b. Then the role of Aire-GCLlo mTECs to mediate 
negative selection in BM chimeras (DEP→ Aire-GCLlo and DEP×∆DC→ Aire-GCLlo) 
was examined. Negative selection occurred no matter DCs were present or not, 
indicating direct presentation by Aire-GCLlo mTECs is efficient to mediate CD4 T-cell 
deletion (Figure 10c-e). To further assess the role autophagy plays on Aire-GCLlo 
mTECs to mediate central CD4+ T-cell tolerance, thymus chimeras that impeded on 
autophagy were generated. T-cell deletion was not affected in transplanted grafts with 
GCL expressing and Atg5 sufficient. In contrast, T-cell deletion was completely 
abolished in transplanted Aire-GCLlo-expressing lobes with Atg5 deficiency, showing the 
total DEP thymocytes were rescued from negative selection (Figure 11a and 11b). 
Taken together, these results demonstrate autophagy-dependent endogenous loading 
on mTECs plays a crucial role for central CD4 T-cell tolerance under an antigen limiting 
condition. 
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Figure 10. Thymocyte development in Aire-GCLlo × DEP TCR-tg double transgenic mice 
and reconstituted BM chimeras. (a) Negative selection in Aire-GCLlo × DEP TCR-tg double 
transgenic mice. Thymi of 4 to 5-week-old DEP single transgenic mice, Aire-GCL×DEP and 
Aire-GCLlo×DEP double transgenic mice were analyzed by FACS. Numbers in the dot plots 
indicate the average frequency ((± stdev) of CD4 SP T-cells (upper row) and of DEP-TCR+ cells 
(Vα11+Vβ5.1+) among gated CD4 SP thymocytes (lower row). (b) Summary of the frequencies 
and absolute numbers of CD4 SP Vα11+Vβ5.1+ cells among total thymocytes in (a). Data in (a) 
and (b) are from at least 8 mice per group. (c) Analysis of CD4+ T-cell development in 4-5 
weeks reconstituted bone marrow chimeras in which DEP bone marrow were transferred into 
irradiated Aire-GCLlo or WT recipients. The average frequency of CD4 SP T-cells are shown (± 
stdev) in upper row and of DEP-TCR+ cells (Vα11+Vβ5.1+) among gated CD4 SP thymocytes 
are depicted (± stdev) in lower row. Values are representative of at least 7 chimeras per group. 
(d) Analysis of CD4+ T-cell development in DEP×∆DC bone marrow chimeras. WT or Aire-GCLlo 
recipients were reconstituted with DEP×∆DC bone marrow and chimeric animals were assessed 
4-5 weeks later. Numbers indicate the average frequency of CD4 SP T-cells are shown (± stdev) 
in upper row and of DEP-TCR+ cells (Vα11+Vβ5.1+) among gated CD4 SP thymocytes are 
depicted (± stdev) in lower row. Values are representative of at least 11 chimeras per group. (e) 
Summary of the frequencies and absolute numbers of CD4 SP Vα11+Vβ5.1+ cells among total 
thymocytes in (c) and (d). (n.s.= not significant.)  
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Figure 11. At limiting antigen expression in Aire-GCLlo mice, autophagy-dependent direct 
presentation by mTECs plays an essential role in central CD4+ T-cell tolerance induction.  
(a) Escape of negative selection on DEP T-cells in transplanted Aire-GCLlo lobes upon 
interference with autophagy in TECs despite in the presence of ‘cross presentation-competent’ 
DCs. Plots depict CD4+ and DEP-TCR+ staining of thymocytes from Atg5+/- or Atg5-/- thymi lobes 
transplanted into DEP×MHC II+/+ recipients measured after 4-6 weeks reconstitution. The 
average frequency of CD4 SP T-cells are shown (± stdev) in upper row and of DEP-TCR+ cells 
(Vα11+Vβ5.1+) among gated CD4 SP thymocytes are depicted (± stdev) in lower row. Values 
are representative of at least 17 chimeras in each group. (b) Frequencies and absolute numbers 
of CD4 SP Vα11+Vβ5.1+ cells among total thymocytes in (a) as compared to WT Atg5+/- 
(n=19 )or Atg5-/- (n=20 )thymic lobes. (P values are indicated; n.s.= not significant.) 
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4. Discussion 
Immunologists have focused on the topic of mTECs since the discovery of the 
autoimmune regulator Aire and its link to the promiscuous gene expression of tissue-
restricted antigens (TRAs) in mTECs157. The mTEC subset is relatively short lived and 
rapidly replaced76. TRAs expressed by mTECs can be efficiently transferred to DCs for 
antigen presentation, which highlights the role of mTEC as antigen reservoir in 
eliminating autoreactive thymocytes and preventing organ-specific autoimmunity84, 235. 
As TEC is the only non-hematopoietic cell that constitutively expresses high levels of 
MHC II, the recognition of MHC class II/peptides on mTECs contributes to the removal 
(negative selection) or deviation (Treg induction) of autoreactive CD4 T-cells228.   
There is a growing number of studies demonstrating that mTECs mediate central CD4 
T-cell tolerance through direct presentation of endogenously expressed self-antigens105, 
231, 232. The most direct evidence supporting the autonomous capacity of mTECs in CD4 
T-cell tolerance came from the study by Hinterberger et al, in which a C2TA-specific 
short hairpin RNA (shRNA) was designed to knock down 90% of MHC class II 
expression on mTECs and the diminished MHC class II expression led to the impaired 
negative selection of CD4 polyclonal and TCR-specific thymocytes along with the 
defective Treg generation230. As TECs display a poor efficiency in capturing and 
processing extracellular antigens, other intracellular processing pathways for MHC class 
II-associated antigens presentation in mTECs are proposed to contribute to mediate 
central CD4 T-cell tolerance.  
Macroautophagy, a bulk protein degradation process that delivers cytoplasmic 
components into lysosomal compartments, has been implicated to shuttle intracellular 
materials into the MHC class II167, 189. Previous results from our lab showed that 
interference with autophagy in TECs led to an altered selection of certain MHC II-
restricted T cell specificities and resulted in multi-organ inflammatory infiltration228. 
However, it remains unclear whether a breakdown of CD4 T-cell central tolerance is 
caused by a defective clonal deletion and/or an impaired Treg deviation mediated by 
autophagy-deficient mTECs or homeostatic expansion of autoreactive T-cells due to 
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impaired positive selection induced by interfering with autophagy on cTECs. We 
addressed this issue by generating a transgenic mouse which expressed a model 
antigen specifically targeted to autophagosome in Aire+ mTECs and evaluating the 
efficiency of autophagy pathway on intracellular antigen shuttling to MIIC in mTECs. 
Based on this, its contribution on mTECs for central CD4 T-cell tolerance was 
investigated. 
4.1 Autophagy pathway required for antigen processing to mediate endogenous 
antigen presentation by mTECs 
Since being discovered, autophagy has been regarded as a non-selective bulk 
degradation process. During the initial formation of autophagosome, the isolated 
membrane indiscriminately engulfs cytoplasmic materials, then elongates and further 
fuses with lysosomes to degrade the sequestered content236, 237. However, 
autophagosomes can also degrade substrates in a selective manner238. Unlike non-
selective autophagy, selective autophagy contains little bulk cytosol between the cargo 
and the vesicle inner membrane239, 240. In mammals, there are two well characterized 
examples of selective autophagy: aggregate-prone proteins241 and bacteria-containing 
autophagosomes242. A polyubiquitin-binding protein p62 (SQSTM1) selectively 
recognizes and links polyubiquitinated proteins with LC3 for further recruiting them to 
autophagosomes220.  
LC3, a mammalian homologue of Atg8, is an essential lipid-anchored protein on the 
surface of preautophagosomal and autophagosomal membranes201, 243. Its incorporation 
into autophagosomes can be monitored in autophagy reporter (GFP-LC3) mice193. In 
MHC class II positive APCs, autophagosomes were found to be continuously fusing with 
multivesicular MIIC. More importantly, by fusion of an antigen to autophagosome-
associated LC3 protein, MHC class II presentation of this antigen increased by 20-
fold189 which implicates this specific antigen-targeting to autophagosomes can deliver 
antigens into MHC class II loading route. That is because as the degradation of LC3 in 
the inner autophagosomal membrane occurs, the fused antigen will be also degraded, 
which provides an opportunity to make the degraded peptides bound with MHC class II 
molecules for antigen presentation. On the basis of this, the tripartite hybrid protein, 
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GCL was generated. Meanwhile, another construct, GCLG120A was generated and 
expressed as a cytosolic antigen. Due to the mutation from Gly to Ala in LC3 protein of 
GCLG120A, it makes the cleavage at the C-terminal region of proLC3 unavailable, thus 
abolishes the conjugation of LC3 to autophagosomal membrane201. This abolishment 
results in the expressed hCRP protein cannot be targeted into autophagosome. Our 
results are consistent with these descriptions presented above. In our study, under 
nutrient deprivation, GFP+ punctae could be observed in HEK 293T cells that expressed 
GCL-vector, in contrast, no segregation of GFP dots were detected in GCLG120A-
expressing HEK 293T cells.  
To investigate whether autophagosome-targeting facilitates antigens to be shuttled into 
mTEC-mediated endogenous MHC class II loading, we generated Aire-GCL and Aire-
GCLG120A mice, in which two closely related variants were expressed in a comparable 
level in mTECs. Analysis of T hybridoma cells activation revealed that contrary to 
GCLG120A, the GCL variant (as an autophagy substrate), was directly presented by 
mTECs and was quantifiable. This observation is in agreement with report described 
that autophagosome-targeting antigen preferentially gained access to MIIC for 
endogenous antigen presentation189. As follows, negative selection on Aire-GCL×DEP 
and Aire-GCLG120A×DEP double transgenic mice was compared. A similar extent of 
negative selection occurred, exhibiting a severe decrease in the total numbers of DEP 
CD4+ thymocytes as well as Treg. Although more Treg differentiation was not found in 
our experiment, there is convincing evidence given that induction of Treg can be 
mediated by both mTECs105, 230 and DCs71 in some TCR transgenic models.  
Since the experiment described above did not observe more favorable T-cell deletion in 
Aire-GCL×DEP mice, in order to better understand the role of mTEC played on negative 
selection, different BM chimeras were designed to remove DCs from the system. 
Analysis of the BM chimeras (DEP×∆DC→Aire-GCL) showed the presence of mTEC-
mediated direct presentation alone is sufficient to induce robust DEP TCR-specific CD4+ 
T-cell deletion. Furthermore, to investigate whether direct presentation depends on 
autophagy in Aire-GCL line, a system with interference of autophagy pathway on 
mTECs was introduced. Analysis of the grafted Aire-GCL×Atg5+/- or Aire-GCL×Atg5-/- 
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lobes in DEP×MHC II-/- recipients showed that autoreactive DEP CD4+ T-cells rescued 
from clonal deletion as a disrupted Atg5 gene was introduced into mTECs, along with 
the results from in vitro assay showed that direct presentation by Aire-GCL mTECs was 
completely eliminated by interfering with autophagy. These findings strongly support our 
hypothesis that autophagy pathway participates in central CD4 T-cell tolerance by 
facilitating direct presentation of endogenous self-antigens in mTECs. 
However, this CD4 T-cell clonal deletion induced by mTEC-mediated direct presentation 
seems not always to depend on autophagy pathway. The study by Aichinger, M. in the 
ePCC/mPCC system244 suggested different subcellular distributions of self-antigens 
might require distinct pathways to gain access to MHC class II in mTECs for negative 
selection. In this system, pigeon cytochrome C (PCC) antigen is expressed in its native 
form as a mitochondrial neo-self-antigen in ePCC; while PCC antigen is expressed as a 
membrance protein on the cell surface in mPCC via addition of a membrane anchor245. 
At first, efficient negative selection of AND CD4 T-cells was not interfered in grafted 
ePCC- or mPCC-expressing lobes with elimination of antigen presentation capacity of 
DCs. It suggested both forms of PCC could be presented directly and efficiently by 
mTECs and further induced AND CD4 T-cell deletion. Furthermore, the role of 
autophagy on TECs for negative selection was analyzed in the AND-Tg×CIITA-/- 
recipients grafted with ePCC×Atg5-/- or mPCC×Atg5-/- lobes. The direct presentation of 
ePCC, but not of mPCC, was abolished due to the interference of autophagy in TECs. It 
has been reported that cell organelles, such as mitochondria, can be selectively 
recruited to autophagosomes by anchoring to the inner autophagosomal membrane. 
With fusion of lysosome/late endosome, autophagosome with its contents are degraded. 
Thus, this process provides a feasible pathway for mitochondrial ePCC to be shuttled 
into MHC class II loading pathway (pathway (a) in Graphic 6). In contrast, as a 
membrane antigen, direct presentation of mPCC by mTECs is independent on 
autophagy. It is probably because a portion of the plasma membrane along with 
molecules coming from the cell surface is pinched off during the typical process of 
endocytosis, and these engulfed molecules may include certain newly synthesized, cell 
surface-residing membrane proteins (such as mPCC mentioned here). And then these 
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contents enter the cytosol as the form of endocytic vesicles. After internalized as early 
endosomes and further matured into late endosomes, the vesicles are delivered to the 
lysosome lumen as well as their sequestered molecules. It makes these membrane 
proteins finally gain access to the MHC class II antigen presentation pathway via 
endocytosis (pathway (b) in Graphic 6), and importantly, this process does not require 
autophagy. The study by Dengjel et, al. provided direct evidence to support the 
existence of distinct pathways in mediating MHC class II presentation for organelle-
derived versus membrane-bound antigens167. The presentation of intracellular-derived 
antigens, including organelles, was significantly increased in a cultured B cell line upon 
induction of autophagy, whereas the presentation of membrance-bound proteins was 
barely affected. 
4.2 The contribution of mTECs versus DCs for central CD4+ T-cell tolerance upon 
a certain threshold of antigen abundance 
Previous studies have reported the expression of Aire in DCs246 and we reproduced this 
observation of a low expression level of Aire gene in DCs. Therefore, it is crucial to 
understand the contribution of DC as antigen reservoir to induce negative selection. In 
BM chimeric mice (Aire-GCL×DEP→WT), in which only the hematopoietic cells could 
potentially express hCRP antigen, no deletion of DEP TCR-specific CD4+ T-cells was 
observed (personal communication with Tomoyoshi, Y.), which excluded the possibility 
of DC as the only source of antigen providing to mediate negative selection. In contrast, 
BM chimeras (DEP→Aire-GCL or DEP→Aire-GCLG120A) recapitulated the phenotype of 
double transgenic mice described above; most of DEP TCR-specific thymocytes were 
deleted, which indicates the expression of antigen exclusively in thymic epithelium is 
sufficient to induce negative selection.  
Two mechanisms account for mediating this remarkable deletion of antigen-specific 
CD4+ T-cells described above. One is the direct presentation mediated by mTECs, and 
the other one is the indirect pathway via DC. However, the contribution of thymic 
epithelial versus hematopoietic cell on negative selection is still controversial. Based on 
existing experimental evidence, we propose at least two parameters governing the 
requirement for direct pathway via mTECs and/or DC-mediated cross-presentation to 
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induce central tolerance. One is the subcellular localization of antigen, and the other is 
the antigen dose. 
Antigens displayed by mTECs seem to preferentially reflect the intracellular milieu of 
this cell type. We suggest that this pool comprises a variety of membrane-associated 
self-antigens (for instance, membrane proteins from mPCC and RIP-mOVA system) as 
well as autophagy substrates (cellular organelles, such as mitochondria or the nucleus). 
In contrast, antigen presentation by hematopoietic APCs in the thymus, especially DCs, 
appears to be optimized to include secretory self-antigens, such as mTEC-derived 
soluble self-antigens in RIP-OVAhi system (pathway (c) in Graphic 6). These newly 
synthesized self-antigens may release into the extracellular space and then are 
endocytosed, processing and presented by neighboring tDCs. The most direct evidence 
came from the observation that OT-II thymocytes were significantly deleted when mTEC 
were the only APC in BM chimeras (OT-II MHC II-/-→RIP-mOVA) compared with WT 
control (OT-II MHC II-/-→WT); whereas in BM chimeras (OT-II MHC II-/-→RIP-OVAhi), 
those OT-II CD4+ T-cells rescued from negative selection in the absence of 
hematopoietic APCs compared to WT control (OT-II MHC II-/-→WT)231. However, to 
some origins of self-antigen, the issue requiring for tolerance induction mediated by 
antigen transferring and presentation via DCs is still not fully understood. It remains 
unclear why negative selection in Aire-GCLG120A at least in part depends on cross 
presentation via DCs (pathway (c) and/or (d) in Graphic 6). The possible explanation is 
that antigen in GCLG120A seems not to be preferentially targeted for mTEC-mediated 
direct presentation, which consists with the finding that MP1 specific CD4+ T-cell 
recognition of MP1-LC3(G120A) was even weaker than that of MP1-LC3
189. Moreover, In 
in vitro and in vivo assay, it had demonstrated that intercellular materials could be 
constitutively, unidirectional transferred from epithelial cells towards DCs121, 122. A 
mature phenotype of thymic DCs harboring the capacity to acquire TEC-derived 
cytoplasmic proteins and to mediate the most efficient cross presentation was 
indentified122. Thus, in Aire-GCLG120A, DC-mediated cross presentation might be the 
major mode to induce efficient CD4+ T-cells deletion. Additionally, mTEC-mediated 
autonomous presentation is also involved to mediate negative selection, even though 
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the direct presentation via mTECs is not autophagy-dependent, which was confirmed by 
our observation in Figure 5c and Supplementary Figure 5, separately.  
 
Graphic 6. The different subcellular localizations of mTEC-derived antigen require 
distinct MHC class II antigen presentation pathways. (a) Autophagy-dependent mTEC-
mediated direct presentation: autophagy substrates (such as mitochondrial ePCC and 
autophagosomal targeting GCL) are specifically targeted into autophagosomes. After fusing with 
late endosomal/lysosomal compartment, autophagy substrates are degraded in MIIC; the 
resulting peptides bind to MHC class II ligands and then transport to the cell surface for 
presentation. (b) Autophagy-independent direct presentation via mTECs: mTEC-expressed 
membrane proteins (like mPCC and mOVA) on the cell surface can be endocytosed to early 
endosomes. After fusing with lysosomes, antigens are degraded and gain access to MHC class 
II loading pathway of mTECs. (c) DC-mediated cross-presentation: mTEC-derived soluble 
antigens (like OVA) and cytoplasmic antigens (like GCLG120A) can be uptaken, and subsequently 
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processed by tDCs for presentation on their MHC class II molecules. (d) Cytoplasmic hCRP 
antigen in GCLG120A may take other pathways (such as CMA) to mediate direct presentation by 
mTECs. 
 
Moreover, the amount of antigen expressed in mTECs is likely to be a driving force to 
influence the contribution of direct pathway mediated by mTECs and indirect pathway 
mediated by DCs, which further to determine the fate of CD4+ T-cells. In our findings, 
we observed efficient DEP CD4+ T-cell deletion in Aire-GCL×DEP double transgenic 
lines even though the expressing transgene varied among lines. Furthermore, negative 
selection of DEP TCR-specific T-cells was barely impaired in a series of bone marrow 
or thymus chimeras which antigen presentation by mTECs or DCs was eliminated in the 
Aire-GCL line. Conceivably, a certain degree of redundancy function of DCs participates 
in inducing a robust CD4+ T-cell negative selection in this system. However, by 
analyzing negative selection induction in the Aire-GCLlo system, it reveals that 
autophagy-dependent mode is essential to induce mTEC-mediated direct presentation. 
The role of DCs played on antigen presentation for central tolerance is excluded in the 
lower transgene expressing system. Comparing to Aire-GCL line, mTECs in this Aire-
GCLlo system perform a 4-fold fewer mRNA expression for transgene, consequentially 
elicit 3-fold weaker DEP T hybridoma stimulation capacity. Collectively, we hypothesize 
a certain threshold of antigen abundance might exist in influencing the contribution of 
mTECs versus DCs for central CD4 T-cell tolerance. That is, when the amount of an 
endogenously expressed antigen by mTECs is above this threshold, the extra antigen 
can be transferred to neighboring DC, which leads cross-presentation mediated by DCs 
for negative selection; otherwise the establishment of negative selection will solely 
depend on mTECs via an endogenous MHC class II loading pathway.   
4.3 Concluding remarks and future perspectives 
Direct antigen presentation mediated by mTECs and indirect pathway via DC-mediated 
presentation of mTEC-derived antigen are proposed to mediate central CD4+ T-cell 
tolerance. It has become apparently that mTECs and DCs differ in their capacity to 
process antigens, which results in a largely non-overlapping self-antigen pool being 
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sampled and presented for T-cell development. However, the pathways involved in 
mediating mTECs to present the intracellular milieu onto their MHC class II ligands are 
still not fully defined. Growing evidence indicate that autophagy can operate as a 
potential pathway for MHC class II endogenous antigen presentation by TECs. In that 
way, it contributes to the composition of MHC class II-bound peptides on cTECs, and 
further regulates thymocytes developing during positive selection. Here we present 
evidence that autophagy on mTECs contributes to induce negative selection of thymic 
CD4+ T-cell and is essential for the generation of a self-tolerant T-cell repertoire.  
Taken together, a model has been proposed here to illustrate the contribution of 
autophagy-dependent endogenous presentation by mTECs and cross-presentation by 
DCs for CD4+ T-cell tolerance in the case of available amount of antigen provided by 
mTECs as a determinant (see Graphic 7). It implicates the patterns of how TRAs 
expressed by Aire+ mTECs might be presented to mediate central CD4+ T-cell tolerance. 
However, whether one of the two Aire-GCL systems could represent to expression of 
physiological self-antigens in mTECs still needs further investigations. Besides the 
study on its function in thymic T-cell education, further studies will be conducted on the 
issue whether autophagy may also participate in the establishment of peripheral 
tolerance to CD4+ T-cells.  
In our study, we focused on the role of autophagy on mTECs for central CD4+ T-cell 
tolerance. However, other alternative pathways might operate in the thymic epithelial 
and/or DCs and are further involved in mediating MHC class II antigen loading. CMA is 
an interesting candidate. It promotes endogenous antigens to be presented onto MHC 
class II ligands of professional APCs during function assays177. However, because of 
the involvement of LAMP-2A and Hsc70 in many basic cellular processes, the genetic 
manipulation to investigate the contribution of CMA on MHC class II loading is hard to 
achieve. In LAMP-2-knockout mice, the issue of CMA contributing to MHC class II 
loading became complex due to the absence of all three isoforms of the LAMP-2 protein 
(LAMP-2A, B and C)247. Therefore, generation of miRNA transgenic mice specific for 
LAMP-2A might be a possible approach. Furthermore, it is found that CMA and 
autophagy are functionally compensable for each other. Blockage of CMA via RNA 
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interference against LAMP-2A could result in a constitutive autophagy activity and vice 
versa248, 249. Thus, the question on what mediates the crosstalk between CMA and 
autophagy pathway also needs to be solved. Additionally, the mechanism of other 
endogenous loading pathways, including microautophagy and the TAP-dependent 
pathway, remains to be elucidated.  
 
Graphic 7. The proposed model for intracellular mTEC-derived antigen transferring and 
its consequences on negative selection to CD4+ T-cells. Endogenous presentation by 
mTECs and cross-presentation by DCs co-operate to mediate CD4+ T-cell tolerance with 
sufficient antigen provided by mTECs (Aire-GCL and ePCC system) in one side, however, both 
pathways perform in a redundant manner. When mTEC-mediated direct presentation is 
abolished via interference of autophagy-related genes, DCs uptake those spreading antigens to 
drive the negative selection process due to the existence of antigen transferring. In the other 
side, when antigen expressed by mTECs is in a limiting dose (Aire-GCLlo system), not enough 
antigen can be transferred to DCs, the role of DCs in negative selection will be completely 
replaced by direct presentation of endogenous self antigens by mTECs, and autophagy on 
mTECs will facilitate this endogenous MHC class II loading route.  
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Supplementary Figure 1 
 
Figure S1. A point mutation of GCLG120A can be distinguished by recognition of the 
restriction enzyme cutting site. (a) PCR genotyping to founder lines using EV4 and LC3-BgIII-
R primers. Note: No.5 (star) and No.7 (heart) from Aire-GCL founders are referred to as Aire-
GCL and Aire-GCLlo lines used in the whole experiment; and No.2 (star) from Aire-GCLG120A 
founders is referred to as Aire-GCLG120A line used in the research project. (b) Amplified PCR 
products from genomic DNA of Aire-GCL and Aire- GCLG120A were digested with or without Nru I.  
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Supplementary Figure 4a  
Figure S4a. Analysis of transgenic protein expression in all Aire-GCL mice. The graph 
showed the transgenic protein expression determined by FACS of respective stromal cells from 
Aire-GCL mice (blue, red, green) compared with WT mice (gray). Note: No.5 (star) and No.7 
(heart) from Aire-GCL founders are referred to as Aire-GCL and Aire-GCLlo lines used in the 
whole experiment. Data are representative of 2-3 independent experiments, each with 4 mice.   
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Supplementary Figure 4b  
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Figure S4b. Analysis of transgenic protein expression in all Aire-GCLG120A mice. The graph 
showed the transgenic protein expression determined by FACS of respective stromal cells from 
Aire-GCLG120A mice (blue, red, green) compared with WT mice (gray). No.2 (star) from Aire-
GCLG120A founders is referred to as Aire-GCLG120A line used in the research project. Data are 
representative of 2-3 independent experiments, each with 4 mice.   
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Supplementary Figure 5 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S5. Negative selection mediated by direct antigen presentation by Aire-GCLG120A 
mTECs is autophagy-independent. Atg5+/- or Atg5-/- thymi lobes from indicated groups were 
transplanted into DEP×MHC II-/- recipients and CD4+ T-cell development was measured after 4-
6 weeks reconstitution. Summary of the frequencies of CD4 SP Vα11+Vβ5.1+ cells among total 
thymocytes (P values are indicated; n.s.= not significant.). Data are representative of at least 10 
chimeras in each group. 
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5. Materials and Methods 
Mice 
TCR-DEP 232, MHC class II-/- (H2-Ab1-/-) 234, Atg5 +/- 206, ∆DC mice233 has been 
described elsewhere. C57BL/6 mice were purchased from Charles River. All mice were 
breed in individually ventilated cages in the animal facility of the Institute for 
Immunology of the University of Munich, Germany. All animal studies were done 
according to the local regulations. 
Antibodies and flow cytometry 
Phycoerythrin (PE)-conjugated monoclonal antibodies (mAbs) to Vα11.1/11.2 (RR8-1), 
Ly51 (BP-1), Phycoerythrin-Cy7 (PE-Cy7)-conjugated streptavidin, Fluorescein 
isothiocyanate (FITC)-conjugated mAbs to Vβ5.1/5.2 (MR9-4) and Biotin-conjugated 
CD80 (16-10A1), CD4 (RM4-5), CD8a (53-6.7) were purchased from Becton Dickinson. 
PE-Cy7-conjugated mAbs to CD4 (GK1.5), CD11c (N418), Phycoerythrin-Cy5 (PE-
Cy5)-conjugated mAbs to CD8a (53-6.7), CD45 (30-F11), Allophycocyanin (APC)-
conjugated mAbs to I-A/I-E (M5/114.15.2), EpCAM (G8.8), Allophycocyanin-cy7 (APC-
cy7)-conjugated mAbs to CD25 (PC61), EpCAM (G8.8) and Biotin-conjugated B220 
(RA3-6B2) were purchased from BioLegend. Monoclonal Ab to MHC class II (P7.7) was 
purified from hybridoma supernatant and conjugated to Alexa Fluor 647 by using the 
Alexa Fluor 647 conjugation kit from Molecular Probes. 4’, 6-Diamidin-2’-phenylindol- 
dihydrochlorid (DAPI) was purchased from Invitrogen. Surface staining of antibodies 
were performed according to standard procedures at a density of 1-2 x 106 per 50 μl 
and volumes were scaled up accordingly. 
Intracellular staining of Foxp3 was performed according to the manufacturers’ protocol 
by using APC-conjugated mAbs to Foxp3 (FJK-16s, eBioscience).  
Flow-cytometric analyses were performed on a FACSCanto II (Becton Dickinson) using 
FACS DIVA (Becton Dickinson) for acquisition and FlowJo (Tree Star) for analysis. 
Cloning of GCL or GCLG120A BAC targeting construct 
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LC3 and LC3G120A cDNA were a kind gift from Prof. Noboru Mizushima. 
In briefly, using designed primers to introduce the appropriate restriction sites, the 
following elements were amplified, subcloned and inserted into pBluescript vector 
backbone in the listed order (5’ to 3’): β-glubin intron was subsequently clones as a 
HindIII/EcoRV fragment, that was PCR amplified from pSG5 construct using primers 
EV8 (CATGAAGCTTGATCGATCCTGAG) and EV9 
(GTCAGATATCAATAACCAGCACGTTGC), following with eGFP was 3’ terminally 
fused to β-glubin intron sequence as an EcoRV fragment, eGFP coding sequence was 
PCR amplified  from pTAGGFP construct, using EcoRV F 
( CCGATATCCGCCACCATGAGCGG) and                EcoRV R  
(AAGATATCCCTGTACAGCTCGTC ) primers, after that with hCRP76-123 sequence, 
which contains DEP-TCR recognized epitope, was amplified as SmaI/PstI fragment 
from Hogness 57 construct using primers EV4 
(GATCCTGCAGTCTAAGGATATAGGATAC) and EV5 
(CGATCCCGGGCTTCCCATCTACCCAGAAC ) amplified and subcloned, and LC3 and 
LC3G120A cDNA BamHI/Xbal digestion fragment was fused at the 3’ terminus to hCRP. 
To destroy triple Myc tag, that was N-ternimally fused to the LC3 protein and its mutated 
version, LC3 and LC3G120A cDNA was PCR amplified from original pCI-neo construct 
using primers Forward 5’- CCGGGATCCCCGTCCGAGAAGACCTT-3’, Reverse 5’- 
TTCTCTAGAGCACCATAGTTATAAACCAG-3’ which introduced BamHI and Xbal 
restriction sites, finally BamHI/Xbal fragment was inserted. The resulting construct was 
used for subsequent BAC modification.   
Constructs containing a β –globin intron followed by cDNAs encoding for GCL or  
GCL G120A, respectively, and a poly-A signal were inserted by homologous 
recombination into the mouse BAC RP23-77011 which contained 58kb downstream and 
152kb upstream from the transcription start site of AIRE (BACPAC). The targeting 
vector contained homology boxes spanning nucleotides -379 to -2 (5’: box1) and 17 to 
399 (3’: box2) of the Aire gene. A neomycin resistance gene flanked by FRT sites was 
used to select successfully recombined clones and was subsequently removed. 
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Autophagy induction in vitro and Microscopic Analysis 
 
 
HEK 293T cells were transiently transfected with pMSCVneo vectors containing the 
plasmids encoding for GCL or GCLG120A by calcium phosphate method. In briefly, HEK 
293T cells were cultured in High Glucose DMEM medium with 5% FCS (vol/vol; 
Biochrom). To avoid cell density is too high, the growing cells should be split at least 2× 
one day before transfection. Meanwhile, 10mM HEPES was added, cell concentration 
was carefully adjusted into 1×105 in 1ml medium and cultured for further transfection. 
The other day, 2.5µg plasmid DNA dissolved in 112.5µl H2O was fully mixed with 12.5µl 
pre-warmed CaCl2 by vortexing, and then 125µl pre-warmed HeBS Buffer was added. 
In the following step, this mixture was added into growing cells, after 6-8h culture, 
freshly pre-warmed medium was added; and after another 48h culture, transfected cells 
seeded onto coverslips in 12-well plates were either starved with medium (Earles 
balanced salt solution with 0.5 μM Rapamycin; both from Sigma-Aldrich) or cultured in 
full medium (DMEM with 8% [vol/vol] FCS; Biochrom) for another 24 h. Subsequently, 
coverslips were mounted onto glass slides with Prolong Gold antifade reagent 
containing DAPI (Molecular Probes) and analyzed by fluorescence microscopy. 
2×HeBS Buffer:   
   16.4g NaCl 
   11.9g HEPES 
   0.21g Na2HPO4   in 800ml H2O 
           
Generation of Aire-GCL and Aire-GCLG120A Mice 
BAC modification 
Transformation of BAC with pBAD 
pMSCV GCL or GCLG120A : 
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DH10β bacteria containing the BAC RP23-77011 which used for modification was 
inoculated in 4ml LB-Cl medium (LB supplemented with Chloramphenicole (12.5µg/ml)) 
and incubated overnight at 37°C. 1ml from the enrichment bacteria was taken and the 
bacteria pellets were harvested by centrifuging at 10,000rpm/min for 2min and 
resuspended by 1ml ice-cold 10% glycerol. After washing for three times, the pellets 
were resuspended in 100ul 10% glycerol and 500ng pBAD vector was added for 
transformation via electroporation using following settings (100Ω, 25µFD, 2.5KV). 
Immediately 1ml LB medium without antibiotics was added and incubated at 37°C for 1h. 
After that, 100µl bacteria was streaked on LB-Cl+Amp plates (LB supplemented with 
Chloramphenicole and Ampicillin (100µg/ml)) and incubated overnight at 37°C. 
Transformation with recombination cassette 
3 colonies were inoculated in 5ml LB-Cl+Amp medium and incubated overnight at 37°C. 
The next day, 1ml cultured bacterial liquid was added into 70ml LB-Cl+Amp medium 
and incubated at 37°C, 300rpm/min for growing till the OD600 value reached to 0.13. 
After that, 14% L-Arabinose (final concentration is 0.2%) was added, bacteria was 
incubated continuously at 37°C with 300rpm/min shaking speed till the OD600 value 
reached to 0.34, this incubation time should be less than an hour. Next, bacteria was 
precipitated by spinning down at 7000rpm/min for 5min and resuspended with 1ml ice-
cold 10% glycerol on ice, and then plastic centrifuge tubes were filled up with glycerol, 
washed for three times. After washing step, the supernatant was discarded and bacteria 
pellets were resuspended in remained glycerol (around 300ul in volumes). 500µg in 5ul 
GCL or GCLG120A digested fragment by restriction enzymes of NotI and PvuI was added 
for transformation by electroporation with the following setting (200Ω, 25µFD, 2.5KV) 
and then 2ml LB medium was immediately added. After 1.5h-incubation at 37°C, 100ul 
bacterial liquid was added on LB-Kana+Cl plates (LB plates with Kanamycin (25ug/ml) 
and Chloramphenicole) for streaking and incubated overnight at 37°C. 
PCR screen of clones positive for the insert 
20 single colonies which grown on LB-Kana+Cl plates were picked up and lysed in 20µl 
sterile H2O by pipetting. 1µl lysate was used to test the successful recombination by 
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PCR and three pairs of primers were chosen.KA9 (ACAGCCACTCCTGTCTTTGC) and 
KA10 (TCCTTCTCCTTCAGACGGAG) identified the empty vectors, KA9 and EcoRV R 
(AAGATATCCCTGTACAGCTCGTC) amplified the positive clones, BamF 
(GGATCCCCGTCCGAGAAGACCTT) and KA10 were used to check for the loss of 
neomycin. TDLong 54×30 PCR program was used in all cases.   
TDLong 54 x 30 program: 
 
                       94° C 3:00 →   1 cycle 
 
    94° C 0:45 
    60° C 0:45   2 cycles 
    72° C 2:00 
 
                                            94° C 0:45 
    58° C 0:45   2 cycles 
    72° C 2:00 
   
                                            94° C 0:45 
    56° C 0:45  2 cycles 
    72° C 2:00 
  
                                           94° C 0:45 
    54° C 0:45  30 cycles 
    72° C 2:00  
    72° C 10:00  1 cycle 
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Deletion of kanamycin resistance 
The positive clones identified by PCR were picked for 1000-fold dilution; one drop from 
the diluted solution was streaked onto on LB-Kana+Cl plates and incubated overnight at 
37°C. 50 clones were picked in the next day and transferred onto two different fresh 
plates (LB-Amp and LB-Kana+Cl plates) by inoculating loop. After overnight-incubation 
at 37°C, the clones which grown on LB-Kana+Cl plates but not LB-Amp were picked, 
indicating the recomninase plasmid has been lost in bacteria. 
The picked clones were inoculated in 5ml LB medium overnight at 37°C. One day later, 
1ml cultured bacteria was added into 100ml LB-Tet+Kana+Cl medium (LB medium 
supplement with Tetracycline and Kanamycin and Chloramphenicole) and incubated at 
37°C till the OD600 value reached to 0.5. And then cultured bacteria was diluted from 
100ml to 250ml and continued to incubate till the OD600 value reached to 0.5 again. Next 
the cultures were rapidly chilled by swirling in water/ice mixture, 100ml bacteria was 
transferred and centrifuged at 4000rpm/min for 7min at 4°C. After centrifugation, the 
bacteria pellets were resuspended gently in 10ml TFBI (transformation buffer I: 30mM 
KOAc, 50mM MnCl2, 100mM KCl, 10mM CaCl2, 15% glycerol (v/v), do not adjust pH, 
sterilize by filtration) and filled up with TFBI. The bacteria was harvested by spinning 
down at 4000rpm/min for 7min at 4°C, and pellets were resupended gently with 1ml 
TFBII (transformation buffer II: 10mM Na-Mops (pH 7.0), 75mM CaCl2, 10mM KCl, 15% 
glycerol). Mixed 50 µl bacteria and 2µl containing 300ng flp-plasmid gently in an 
Eppendorf tube and incubated on ice for 30min, transferred into 42°C water bath for 
1min, and then 350µl LB medium was added for 1h-incubation at 30°C. After that, 20µl 
bacteria were streaked onto LB-Tet plate (LB plate supplement with Tetracycline) and 
incubated overnight at 30°C. In order to delete the kanamycin resistance from bacteria, 
10 clones were picked up and transferred into 2ml LB medium without antibiotics with 
30°C incubation for 1h and following with 37°C incubation for 5h, which gives them a 
chance to lose the flp-plasmid. And then 20µl was taken for streaking onto each of LB-
Amp, LB-Kana+Cl or LB-Cl plate. The next day, 6 clones which only grown on LB-Cl 
plate but not on either LB-Amp or LB-Kana+Cl plate were picked and cultured in 5ml 
LB-Cl medium overnight at 37°C. The correct inserted fragment and direction was 
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checked from the picked clones via make DNA mini-preparation, PCR amplification and 
sequencing. 50µl from 1000-times diluted culture of 3 correct clones was used for 
streaking onto LB-Cl plates. 
Large scale preparation of BAC DNA and purification 
A single colony with the correctly targeted BAC was picked from a freshly streaked LB-
CL plate and incubated in a starter culture of 4ml LB-CL medium for approximately 8h at 
37°C with 300rpm/min shaking. 500µl of the starter culture were added into 4 flasks 
which contain 500ml LB-CL medium and cultured at 37°C 300rpm/min for 14h to make 
bacteria growing. When time is up, bacteria were harvested in 200ml plastic centrifuge 
tubes by centrifugation at 6,000g in a refrigerated superspeed centrifuge equipped with 
a GSA rotor (Sorvall) at 4°C. BAC isolation was carried out according to the 
manufacturer recommendation of the large construct kit (Qiagen) with some 
modification to the supplied protocol. Pellets from 500ml of the 14h cultured bacteria 
were resuspended in 30ml Buffer P1 with RNase A (Qiagen), supplemented with 
LyseBlue reagent (Qiagen). Hereafter, 30ml Buffer P2 (Qiagen) were added and the 
plastic centrifuge tubes were agitated gently, but thoroughly, to make sure the solution 
were completely mixed, as indicated by a homogenously blue solution, and then kept 
the mixture incubating at room temperature for 5min.  Next added 30ml chilled Buffer P3 
and agitated the plastic centrifuge tubes gently, but thoroughly, to make sure the 
solution were fully mixed with a symbol which blue color fade out and a fluffy white 
material formed. It is crucial to be as gentle as possible here, as too harsh agitation will 
result in shearing and subsequent exonuclease digestion of large amounts of BAC DNA. 
After keeping incubation on ice for 10min, the mixture was centrifuged at 14,000g in the 
same rotor as before for 30min at 4°C. Cleared supernatant containing BAC DNA was 
separated from non pelleted debris by filtering through a water-prewetted folded filter 
(supplied in the kit), and DNA was precipitated by adding 0.6 volumes room-
temperature isopropanol (Fluka) and centrifuging at 14,000g for 30min at 4°C. After 
carefully decanting the supernatant, DNA pellets were washed with 5ml room-
temperature 70% (v/v) ethanol (sigmal) and air-dried for 3min. Next the DNA pellets 
were dissolved in 9.5ml Buffer EX (Qiagen) carefully and completely by very gentle 
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shaking. After that, ATP (sigma) to a final concentration of 3.16mM and 300µl ATP-
dependent exonuclease (supplied with the large construct kit) was added and incubated 
in a water bath at 37°C for 60min in order to remove the genomic DNA and nicked BAC 
DNA. Next 10ml Buffer QS (Qiagen) was added to the DNA sample, filtered through a 
70µm cell strainer (BD Falcon), and loaded onto QIAGEN-tip 500 columns which were 
pre-equilibrated with Buffer QBT (Qiagen), The empty columns were washed twice with 
30ml Buffer QC (Qiagen) and DNA was eluted with 15ml pre-warmed Buffer QF 
(Qiagen). Eluted DNA was precipitated by adding 0.7 volumes room-temperature 
isopropanol and then centrifuged at 3,000g for 60mins at 4°C, and washed with 5ml 
room-temperature 70% ethanol, again pelletted at 3,000g for 60min at 4°C and air dried 
for approximately 10min and dissolved at room temperature in 200-400µl aqua ad 
injectabile (Braun), depending on pellet size. 
The purified BAC was immediately linearized with the appropriate restriction enzyme 
NruI. Briefly, the BAC was incubated at 37°C in the presence of 100U NruI (New 
England Biolabs) in the presence of the appropriated reaction buffer in 400µl reactions. 
Completeness of reactions was verified on a 1% (w/v) agarose (Sigma)/TAE gel. 
Following linearization BAC DNA was cleaned up using a standard phenol based 
extraction protocol. Briefly, 1 volume of phenol:Chloroform:isoamylalcohol (25:24:1) 
(Sigma) was added, thoroughly mixed and centrifuged at 10,000g for 10min. The 
aqueous phase was then transferred into a fresh tube and 0.1 volumes of 3M sodium 
acetate pH5.2 (Sigma) was added followed by the addition of 3 volumes of absolute 
ethanol (AppliChem), vigorous mixing and incubation for 10min at room temperature to 
precipitate the DNA. The DNA was pelletted by centrifugation at 20,000g for 10min 
followed by 5 washing steps with 70% (v/v) ethanol (Sigma). After briefly air drying the 
pellet, the DNA was dissolved in aqua ad infectabile (Braun) followed by the addition of 
1 volume 2×BAC injection buffer. Finally the BAC DNA was quantified on a 1% (w/v) 
agarose/TAE gel by running it along with 100bp and 1kb length markers (Fermentas). 
10× injection buffer 
1830ml H2O 
160ml TRIS (1M, pH 7.5) 
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4ml EDTA (0.5M) 
NaCl (100mM final) 
BAC DNA preparation for pronuclear injections 
Tg mice were generated by injection of linearized BAC DNA into pronuclei of C57BL/6 
zygotes. For pronulear injuctions DNA was diluted in injection buffer to a concentration 
of 1 ng/ml. Microinjection was performed by Ronald Naumann at the Max Planck 
Institute of Molecular Cell Biology and Genetics, Dresden, Germany.  
 
Generation of NFAT-GFP Reporter Hybridoma Cells 
The T1CRP-54.4 hybridoma expressing the DEP TCR was infected with the retroviral 
vector which contains the construct SIN-(NFAT)x-GFP (250provided by H. Spits, 
Academisch Medisch Centrum, Amsterdam). Subclone 32–14 was used for in vitro 
stimulation experiments. 
Preparation and Purification of Thymic Stromal Cells 
Thymi were disenthralled from connective tissue and fat, cut into very small pieces 
using scissors and transferred to pre-warmed digestion medium (IMDM containing 0.2 
mg/ml Collagenase (Roche), 0.2 mg/ml DispaseI (Roche), 2% FCS, 25mM HEPES (pH 
7.2) and 25 μg/ml DNase I (Roche)). 1ml digestion medium was used per thymus. 
Digestion was performed in a FACS tube at 37 °C for 35min (the single cell suspension 
was resuspended in every 5min with a 1000µl pipette) , and then cells in the FACS tube 
were transferred on ice and digestion process was blocked by adding 1:100 0.5M EDTA 
and then incubated for 10min. cells were filtered and washed with FACS buffer once. 
The supernatant was discarded and pellet was resuspended in 1ml high density percoll 
(GE Healthcare; ρ=1.115), then carefully added 1ml low density percoll (ρ=1.055) on the 
top, following added 1ml FACS buffer and did gradient centrifuge (4°C, 30min, 1350g). 
After that, the upper interphase, containing the desired low density fraction, was 
removed and resuspened in 3ml FACS buffer, and were ready to staining. 
The Percoll solutions were prepared as follows:  
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High density percoll (ρ=1.115) Low density percoll (ρ=1.055) 
9×Percoll stock (ρ=1.134) 
1×PBS (10×) 
25mM HEPES pH=7.2 (final) 
1×Percoll (ρ=1.115) 
1.09×PBS (1×) 
 
 
Antigen Presentation Assay 
2×104 T1CRP-54.4/ SIN-(NFAT)x-GFP (clone 32-14) hybridoma cells were co-cultured 
with 1×104 thymic APC s in 150µl High Glucose IMDM w/o Phenol Red (PAA) 
supplemented with 8% FCS (v/v) (Biochrom). After culturing for 20h, GFP expression 
was measured by FACS. 
Bone Marrow Chimeras 
The femurs of the donor mice were isolated and placed in a petrel dish (on ice) 
containing sterile PBS buffer (pH=7.2), and then the femurs were flushed to harvest 
bone marrow with PBS buffer by using a 25G 5/8 needle.  To remove bits of bone, the 
cell suspension was filtered and collected in a 50ml tube, and then centrifuged at 600g 
for 5min. After that, cells were washed with FACS buffer once; in order to deplete of T-
cells and B-cells in bone marrow, cell pellets were resuspended in master mixture of 
biotin-labeled antibodies (CD4, CD8 and B220) and incubated on ice for 20min. After 
washing with FACS buffer, pellets were resuspended with appropriated amounts of 
streptavidin MACS beads (Miltenyi Biotec) and incubated at 4°C for 20min. After 
incubation, cells were washed, resuspended with MACS buffer and went through 
column. The flow through fractions were harvest and washed with FACS buffer. The cell 
number was counted and adjusted into the suitable concentration, and 5×106 bone 
marrow cells in 300µl was injected i.v into recipient mice, which got two times of 550 rad 
irradiation.  
Thymus Transplantation 
E14-16 thymi were transplanted under the kidney capsule of female animals. Atg5–/– 
embryonic thymi and Atg5+/- WT controls in individual experiments were obtained from 
Atg5+/-pregnant female after mating to the same Atg5+/- male. 
90 
 
Semiquantitative RT-PCR 
Sorted different subsets of thymic stromal cells (purity ≥90%) were used for RNA 
purification. Total RNA from no less than 10,000 cells was purified by using miRNeasy 
Mini Kit (Qiagen); the procedure was executed according to manufacturer’s instruction . 
DNA carryover in isolated RNA was removed with a process named on-column DNase 
digestion. Reverse-transcription for purified RNA was conducted by using iScript cDNA 
synthesis kit (Biorad) according to the manufacturer instructions.  
qPCR in a 10µl reaction (4µl cDNA template+1µl mixed primers+5µl SsoFast EvaGreen 
Supermix (Biorad)) was performed with duplicates in a CFx96 Real-Time thermal cycler 
(BioRad) according to the manufacturer instruction. Primers were used in 500nm for 
each.  
qPCR reaction program: 
                                            95° C 30s →           1 cycle 
 
     95° C   3s 
                                          40 cycles 
                                            56° C   5s   
     
                                            65-95° C, 3s/step            1 cycle 
Primers used for qPCR: 
gene primer sequence 
Aire-GCL or 
Aire-GCLG120A 
 
YW103 5'   TTCTGGGTAGATGGGAAGCC   3’ 
YW104 5'   CCCTTGTATCGCTCTATAATCACT 3’ 
Aire 
 
Aire fwd 5’   GAGTCACAGCACCTTCCTCTT    3’ 
Aire rev 5’   GGGACAGCCGTCACAACA         3’ 
β-actin 
 
β-actin fwd 5’   GGTGGGAATGGGTCAGA           3’ 
β-actin rev 5’   GAGCATAGCCCTCGTAGAT       3’ 
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Statistical Analysis 
Statistical significance was assessed using the unpaired two-tailed Student’s t test. 
 
Supplementary Methods-Genotyping Primers 
Genotyping 
DNA preparation 
Tails were incubated in 50µl digestion buffer at 55°C for 5h, and then proteinase K was 
inactivated at 95°C for 5min. 
Gitocher digestion buffer (10×) 
670mM Tris pH 8.8 
166mM ammonium sulfate 
65mM MgCl2 
0.1% Gelatin 
Digestion buffer 
3µl Proteinase K (10mg/ml stock) 
2.5µl Triton (10% stock) 
5µl Gitocher Buffer (10×) 
0.5µl β-Mercapto-ethanol 
39µl H2O 
PCR Red-buffer (5×) 
250mM KCl 
50mM Tris pH 8.3 
43% Glycerol 
7.5mM MgCl2 
2mM Cresol Red 
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For genotyping, the following primers were used: 
gene primer sequence 
Aire-GCL or  
-GCLG120A 
GCL fwd 5'  GATCCTGCAGTCTAAGGATATAGGATAC 3' 
GCl rev 5'  TTCAGATCTGCACCATAGTTATAAACCAG  3' 
TCR-DEP LK28 fwd 5'  CGAGAGGAAGCATGTCTAAC   3' 
LK29 rev 5'  ACCGCGGTCATCCAACACAG    3' 
CD11c-Cre Cre fwd 5'  CGATGCAACGAGTGATGAGG  3' 
Cre rev 5'  GCATTGCTGTCACTTGGTCGT  3' 
DTA DTA fwd 5'  TACATCGCATCTTGGCCACG      3' 
DTA rev 5'  CCGACAATAAATACGACGCTG  3' 
MHC II wt MHC II wt fwd 5’  TTCGTGTACCAGTTCATGGG      3’ 
MHC II wt rev 5’  TAGTTGTGTCTGCACACCGT      3’ 
MHC II ko MHC II ko fwd 5’  TTCGTGTACCAGTTCATGGG      3’ 
MHC II ko rev 5’   CCTGCCGAGAAAGTATCCA       3’ 
Atg5  wt LK 39 fwd 5'   GAATATGAAGGCACACCCCTGAAATG  3' 
LK 41 rev 5'   GTACTGCATAATGGTTTAACTCTTGC     3' 
Atg5 ko LK 40 fwd 5'   ACAACGTCGAGCACAGCTGCGCAAGG  3' 
LK 41 rev 5'   GTACTGCATAATGGTTTAACTCTTGC      3' 
 
PCR program: 
TD 54 x 30: for TCR-DEP, DTA-floxed, MHC II ko, Aire-GCL and Aire- GCLG120A 
genotyping. 
                        94° C 3:00 →   1 cycle 
    94° C 0:45 
    60° C 0:45   2 cycles 
    72° C 1:00 
                                            94° C 0:45 
    58° C 0:45   2 cycles 
    72° C 1:00 
                                           94° C 0:45 
    56° C 0:45  2 cycles 
    72° C 1:00 
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                                            94° C 0:45 
    54° C 0:45  30 cycles 
    72° C 1:00  
    72° C 10:00  1 cycle 
 
CD11c-Cre genotyping program: 
                                            94° C 3:00                1 cycle 
                                            94° C 0:30 
               56° C 0:30  38 cycles 
               72° C 1:00 
                                            72° C 10:00  1 cycle 
 
    
Atg5 genotyping program: 
                                            94° C 3:00                1 cycle 
                                            94° C 0:30 
               58° C 0:30  36 cycles 
               72° C 0:30 
                                            72° C 10:00  1 cycle 
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